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Abstract 
 
Cancer cells display enhanced growth rates and a resistance to apoptosis. Lung 
cancer accounts for the most cancer related deaths and non-small cell lung cancer 
(NSCLC) represents an aggressive form of lung cancer, accounting for almost 80% of all 
lung cancer cases. The phytochemical rosemary extract (RE) has been reported to have 
anticancer effects in vitro and in vivo however, limited evidence exists regarding the 
effects of RE and its polyphenolic constituents carnosic acid (CA) and rosmarinic acid 
(RA) in lung cancer. The present study shows RE, CA and RA inhibit lung cancer cell 
proliferation and survival in various NSCLC cell lines and that CA and RA interact 
synergistically to inhibit cell proliferation. Moreover RE, CA and RA are capable of 
altering activation and/or expression of Akt, ERK and AMPK, signaling molecules which 
regulate cell proliferation and survival. RE shows potential as an anticancer agent and 
should be further investigated. 
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Chapter 1: Literature Review 
 
1.1 Cancer 
 Cancer originates within the nucleus of the cell, the body’s basic unit of life. 
Arguably the most fundamental traits of cancer cells are their enhanced proliferative and 
decreased apoptotic capacities (Figure 1) [1]. Normal cells tightly control the production 
and release of growth factors which regulate cell growth/proliferation, thereby ensuring 
cellular homeostasis and maintenance of normal tissue architecture. In cancer cells these 
signals are deregulated and thus, homeostasis within the cell is disrupted. Proliferation of 
cancer cells may be enhanced in a number of ways. Cancer cells may produce growth 
factors, to which they can respond via the expression of cognate receptors. The level of 
receptor proteins displayed on the surface of cancer cells can also be elevated, rendering 
these cells hyperresponsive to growth factors; the same outcome can result from 
structural alterations to the receptor molecules that facilitate activation of downstream 
signaling pathways independent of growth factor binding [1]. Alternatively cancer cells 
can signal normal neighbouring cells resulting in mutation/alterations in signaling 
pathways. These alterations stimulate the release of growth factors which are supplied 
back to the cancer cells, enhancing their proliferation [2,3].  
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Figure 1: Disruption of proliferation and apoptosis in cancer. Enhanced proliferation 
and/or inhibition of apoptosis are the fundamental traits of cancer cells compared to their 
healthy counterparts, which proliferate and undergo apoptosis in a controlled fashion, 
maintaining homeostasis. 
 
Growth factor receptors (GFR) are plasma membrane proteins with intrinsic 
tyrosine kinase (TK) activity. Growth factor binding enhances the tyrosine kinase activity 
of the receptor causing receptor autophosphorylation. The phosphorylated tyrosine 
residues of the receptor act as docking sites for intracellular proteins containing Src-
homology 2 (SH2) domains, leading to stimulation of intracellular signaling cascades that 
result in enhanced proliferation and/or inhibition of apoptosis (Figure 2). Epidermal 
growth factor (EGF) signaling is established to play a major role in cancer and for this 
reason information focused on the EGF receptor and its signaling will be presented in the 
following sections. In addition, the phosphatidylinositol 3-kinase (PI3K-Akt), the Ras- 
mitogen activated protein kinase (Ras-MAPK) and the 5’ adenosine monophosphate-
activated kinase (AMPK) will be presented because of their significant role in cancer.  
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Figure 2: Cell proliferation and survival pathways. The PI3K-Akt, Ras-MAPK and 
AMPK signaling pathways play a significant role in cancer and are involved in regulating 
cell proliferation, survival and apoptosis.  
 
1.2 EGFR signaling  
The epidermal growth factor receptor (EGFR) family of tyrosine kinase receptors 
in humans includes human EGFR (HER1) or (ErbB1), HER2/neu (ErbB2), HER3 
(ErbB3) and HER4 (ErbB4) [4,5]. EGFR (HER1/ErbB1) is a 170 kD transmembrane 
protein consisting of an N-terminus extracellular ligand-binding site, a hydrophobic 
transmembrane domain and a C-terminus intracellular region with tyrosine kinase activity 
[6,7]. 
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The four members of the HER family are capable of forming homo- and 
heterodimers upon ligand binding. Receptor dimerization is required for receptor 
activation under normal physiologic conditions. However, these receptors can be 
additionally activated due to increase in receptor gene copy number, receptor over-
expression, and activating mutations [8], including deletion of exon 19 and a single-point 
substitution in exon 21 which  are both found in the tyrosine kinase domain of the 
receptor and constitute about 90% of all EGFR activating mutations [9]. 
EGFR is overexpressed as a result of gene amplification in many cancers [10]. 
Overexpression or mutation of EGFR is common in tumors of epithelial origin, and has 
been shown in head and neck [11], breast [12], and non-small cell lung [13] cancer cells, 
among others. Activating mutations (mentioned above) in the EGFR gene lead to 
increased signaling through associated downstream pathways. Patients whose tumors 
express high levels of EGFR have a poor prognosis [14] and this makes EGFR an 
attractive target in cancer therapy; and its inhibition a strategy for augmentation of the 
efficacy of chemo- and radiotherapy [15]. Activation of EGFR leads to downstream 
activation of the PI3K/Akt and Ras/MAPK signaling cascades. 
1.3 PI3K-Akt/PKB axis 
The phosphatidylinositol 3-kinase (PI3K) family are lipid kinases that 
phosphorylate phosphatidylinositol (PI) substrates, leading to subsequent activation of 
downstream proteins and cell survival and proliferation. Typically substrates include PI, 
phosphatidylinositol-4-phosphate (PIP) and phosphatidylinositol-4,5-bisphosphate (PIP2) 
and the corresponding products are phosphatidylinositol-3-phosphate (PIP) 
phosphatidylinositol-3,4-bisphosphate (PIP2) and phosphatidylinositol-3,4,5-
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
5 
 
trisphosphate (PIP3). The most predominant product in vivo is PIP3, produced following 
phosphorylation at the 3’-OH position of the inositol ring in PI-4,5-P (PIP2) by PI3K. 
The PI3K molecule contains a regulatory (p85) subunit and a catalytic (p110) subunit 
[16,17]. The p110 subunit contains 5 binding domains, including an N-terminal adaptor-
binding domain (ABD) which binds to p85, a Ras-binding domain, a putative membrane-
binding domain (C2), a helical domain and a kinase catalytic domain. The p85 regulatory 
subunit contains an SH2 domain which interacts directly with the tyrosine phosphate 
motifs of the activated tyrosine kinase receptor, recruiting the PI3K complex to the cell 
plasma membrane. The SH2 is a structurally conserved protein domain which allows 
docking to phosphorylated tyrosine residues on other proteins [18]. This binding removes 
inhibition of the p110 catalytic subunit which proceeds to phosphorylate membrane 
phospholipids. PIP3 serves as a docking site in the plasma membrane for proteins 
containing pleckstrin homology (PH) domains, such as Akt. 
There are three subclasses of PI3K (Class I-III) based on structure, regulation and 
substrate specificity. Class II and III vary from Class I in structure and function, both 
containing a single catalytic subunit, without a regulatory subunit. Class II preferentially 
use phosphatidylinositol (PI) or phosphatidylinositol-4-phosphate (PIP) as substrates, 
while Class III use only PI as a substrate. Class I can use PI, PIP and PI-4,5-P (PIP2) as a 
substrate, with PIP2 being  the preferential substrate in vivo [17]. Class I can be further 
divided into class IA which can be activated by receptor tyrosine kinases, G-protein 
coupled receptors (GPCR) and oncogenes, and class IB which can be activated only by 
GPCRs [19].  
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The PIK3CA gene encodes the catalytic subunit (p110ɑ) of PI3K and was 
discovered to be somatically mutated in a significant fraction of diverse tumor types [20–
22]. This mutation results in a constitutively activated PI3K and associated downstream 
molecules such as Akt leading to enhanced cell survival capabilities. Mutations in exon 9 
or 20 of the PIK3CA gene have been associated with lower relapse-free survival in 
patients with stage II or III colorectal cancer [23] and progression-free survival with 
cetuximab (EGFR inhibitor)-based therapy in patients with colon cancer was significantly 
lower when tumors carried mutations in the PIK3CA gene [24]. The PI3K-Akt signaling 
pathway can be seen in Figure 3. 
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Figure 3: The PI3K/Akt cell signaling pathway is involved in regulating cell survival 
and proliferation pathways which are often deregulated in cancer cells. 
 
Akt, also known as protein kinase B (PKB) is a serine/threonine- specific protein 
kinase located downstream of PI3K. The mammalian genome contains 3 Akt genes, 
encoding the isoforms Akt1, Akt2 and Akt3. Akt2 and Akt3 have 81 and 83% amino acid 
sequence homology with Akt1 respectively [25]. Each gene encodes a protein containing 
a pleckstrin-homology (PH) domain in the N-terminus, a central kinase domain, and a C-
terminal regulatory domain [26]. All 3 mammalian Akt genes are widely expressed in 
various tissues, but Akt1 is most abundant in brain, heart and lung, whereas Akt2 is 
predominantly expressed in skeletal muscle and embryonic brown fat, and Akt3 is 
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predominantly expressed in brain, kidney and embryonic heart [27–30]. Akt, through its 
(PH) domain, binds to PIP3 and once at the membrane, Akt is phosphorylated at two 
sites; Thr308 by phosphoinositide-dependent kinase (PDK1) and Ser473 by PDK2 [26], 
resulting in full activation of its kinase activity and downstream phosphorylation of 
numerous protein targets [20]. A constitutively active Akt has been functionally linked 
with a poor prognosis in many human cancers [17,31–35]. Additionally, Akt activity 
promotes resistance to chemo- and radiation therapy [36–38]. 
The levels of membrane-bound PIP3 are tightly regulated by phosphatases such as 
the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) [39] which 
acts to reduce PIP3 levels. Loss of PTEN increases the activity of the PI3K/Akt cascade 
leading to enhanced proliferation and survival, and cancer [21,22]. 
1.3.1 mTOR  
 Mammalian target of rapamycin (mTOR) is a serine/threonine kinase located 
downstream of Akt in the cell survival pathway (Figure 3). Activation of mTOR requires 
the recruitment of multiple molecules to form a complex. mTOR complex 1 (mTORC1) 
consists of mTOR, regulatory-associated protein of mTOR (RAPTOR), mammalian 
lethal with SEC13 protein 8 (MLST8) and DEP domain-containing mTOR-interacting 
protein (DEPTOR) [40]. Akt activates mTOR through (i) phosphorylation and inhibition 
of tuberous sclerosis complex 2 (TSC2), which allows the mTOR-activating GTPase 
Rheb to remain in its GTP-bound (active) state and/or (ii) phosphorylation and removal 
of proline rich Akt substrate 40 (PRAS40), a Raptor inhibitor [41]. Active mTORC1 
promotes gene expression and translation through phosphorylation-mediated activation of  
p70S6 kinase (p70S6K) and phosphorylation-mediated inhibition of eukaryotic 
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translation initiation factor 4E-binding protein 1 (4EBP1) [41,42]. Enhanced activation of 
the mTOR signaling pathway has been reported in a variety of human cancers including 
malignant melanoma [43] and head and neck cancers [44]. Recent evidence has shown 
that two different single amino acid mutations in mTOR, S2215Y and R2505P, identified 
in the human cancer genome database, confer activation of mTORC1, and cells 
expressing the S2215Y mutant mTOR exhibited altered cell cycle profile [45]. 
1.4 Ras-MAPK axis 
 
 The Rat sarcoma (Ras) family of proteins are oncogenic GTPases and function as 
a molecular switch that cycles between a GDP-bound inactive state and a GTP-bound 
active state, regulating processes governing cell proliferation, survival and differentiation 
[46]. The three mammalian Ras genes (H-, K- and N-Ras) encode the four Ras proteins: 
HRas, KRas4A, KRas4B and NRas and display extraordinary similarities. These proteins 
are all 21 kDa, are identical over the 85 N-terminal residues and their identity within the 
following 80 residues is up to 90% [47]. 
The growth factor receptor-bound protein 2 (Grb2) is a docking protein 
containing a Src homology 2 (SH2) binding domain and 2 Src homology 3 (SH3) 
domains. The SH3 domains allow binding of the guanine nucleotide exchange factor sons 
of sevenless (SOS). Following ligand binding to the GFR and receptor 
autophosphorylation, the SH2 domain of Grb2 binds to the phosphorylated tyrosine 
residues on the GFR, and this activates SOS. Activated SOS promotes the removal of 
GDP from membrane-bound Ras and addition of GTP. The GTP-bound Ras is now in an 
active state and can proceed to recruit and activate the serine/threonine protein kinases C-
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Raf and B-Raf, which form a heterodimer. Activated Raf phosphorylates and activates 
the tyrosine/threonine mitogen-activated protein kinase kinase (MEK 1/2), which in turn 
phosphorylates and activates the mitogen activated protein kinases (MAPK). MAPKs are 
evolutionarily conserved kinase modules that link extracellular signals to the machinery 
inside the cell that controls fundamental cellular processes such as growth and 
differentiation. Phosphorylation of MAPK by MEK leads to phosphorylation of  
downstream targets including transcription factors that lead to cell growth and survival  
(Figure 4) [47]. 
 Alternatively, activated Ras is capable of activating the p110 catalytic subunit of 
PI3K, independent of regulatory subunit p85, leading to subsequent activation of Akt and 
cell survival as described previously (Figure 3) [48]. 
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Figure 4: The Ras/MAPK cell signaling pathway is involved in regulating cell growth 
and proliferation and signaling through this pathway is often deregulated in cancer cells. 
 
 Activating mutations in KRAS (gene encoding Ras) are common in cancer and 
stimulate  downstream cascades [49]. Most oncogenic forms of Ras impair their intrinsic 
GTPase activity, preventing GTP hydrolysis and locking Ras in a GTP-bound activated 
state. Point mutations in the Ras protein can occur at codon 12, 13 or 61, but are most 
common (97% of the time) at codons 12 and 13, which can be found in the amino acid 
loop that interacts with the phosphate group of GTP with the help of GTPase-activating 
proteins (GAP) [46].  
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Mutations in KRAS account for 90% of Ras mutations in lung adenocarcinomas. 
It is the most commonly mutated oncogene in non-small cell lung cancer (NSCLC), with 
mutations detected in about 25% of all tumors. The presence of KRAS mutations has 
been shown to portend a poor response to monotherapy and combination therapy using 
EGFR inhibitors, such as cetuximab or panitumumab, in primary colorectal cancer [50–
52]. Similarly, patients with KRAS-mutant tumors treated with cetuximab in any 
combination, had lower progression-free survival compared to those with wild type 
KRAS tumors [24,53,54] suggesting that KRAS mutation may bypass aberrant EGFR 
signalling. This evidence linking KRAS mutations with poor response to EGFR inhibitors 
now influences treatment decisions in the clinic, and highlights the importance of 
examining the tumor mutation profile.  
1.5 AMPK 
 
5’-adenosine monophosphate-activated protein kinase (AMPK) is an energy 
sensing protein kinase that is important in regulating cellular homeostasis and protecting 
cells under conditions of metabolic stress. AMPK is a highly conserved heterotrimeric 
kinase complex composed of a catalytic ɑ subunit and two regulatory (β and γ) subunits. 
The ɑ and β subunits can exist as 2 different isoforms (ɑ1, ɑ2; β1, β2) while the γ subunit 
can exist as 3 isoforms (γ1, γ2, γ3). The most common isoforms expressed in most cells 
are the ɑ1, β1 and γ1 isoforms however, the other isoforms have been found to be 
expressed in cardiac and skeletal muscle [55]. Modulation of AMPK activation is shown 
in Figure 5.  
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Figure 5: The AMPK signaling pathway. AMPK becomes activated under conditions 
of cellular stress and low ATP. Increases in glycolytic rate and mutations in LKB1 often 
result in decreased AMPK activity in cancer. 
 
Activation of AMPK occurs when there is an increased concentration of AMP and 
a fall in ATP within the cell, through phosphorylation by tumor suppressor liver kinase 
B1 (LKB1) or by the calcium/calmodulin-dependent protein kinase kinase (CaMKKβ). 
When ATP levels in the cell drop, resulting in increased AMP, two AMP molecules bind 
the 2 Bateman domains of AMPK which are found in the γ subunit. Each Bateman 
domain is a pair of cystathionine beta synthase (CBS) protein domains. AMP binding 
results in a conformational change of the γ subunit, exposing the threonine-172 (Thr-172) 
site on the catalytic ɑ subunit. The serine/threonine kinase LKB1 is a tumor suppressor 
mutated in Peutz-Jeghers syndrome [56] that leads to tumor growth by phosphorylating 
and thus activating the exposed activating loop on Thr-172 in the ɑ subunit. When 
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complexed with STe20 Related Adaptor (STRAD) and Mouse protein-25 (MO25), LKB1 
shows constitutive activation and localization in the cytosol [57]. The increased levels of 
AMP within the cell also act to prevent dephosphorylation of the Thr-172 residue, 
rendering AMPK a better substrate for LKB1 phosphorylation and activation [55,58]. 
Alternatively, AMPK can be phosphorylated and activated on its Thr-172 residue by 
CaMKKβ when intracellular calcium levels increase such as during exercise [59].  
Somatic inactivation mutations and genetic loss of the LKB1 gene are found in a 
significant number of lung and cervical cancers, greatly reducing phosphorylation of 
AMPK at Thr-172 and thus its activity within these cells [60].  
 Activation of AMPK increases cellular energy levels by inhibiting anabolic 
energy consuming pathways and stimulating energy producing catabolic pathways. Once 
activated, AMPK inhibits anabolic processes and protein synthesis by inhibiting 
mTORC1 through (i) Ser1387 phosphorylation and activation of TSC2, leading to 
inhibition of Rheb GTPase activity and thus mTOR inhibition, or (ii) direct 
phosphorylation and inhibition of mTOR-binding partner Raptor [61]. AMPK 
phosphorylates and inhibits acetyl CoA carboxylase (ACC), a key regulator of fatty acid 
and glycerol lipid syntheses. Two isoforms of ACC exist, and AMPK inhibits this 
molecule by phosphorylating serine 79, 1200 and 1215 residues on ACC1 and serine 218 
on ACC2. ACC is the rate limiting enzyme for malonyl-CoA synthesis, which leads to 
inhibition of fatty acid oxidation. Thus, following activation of AMPK and subsequent 
inhibition of ACC, malonyl-CoA synthesis is decreased leading to enhanced fatty acid 
oxidation and ATP production, restoring cellular energy levels.  
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
15 
 
It has been observed that the activation of AMPK in cancer cells leads to 
suppression of cell growth through inhibition of protein synthesis and up-regulation of 
the p53 pathway leading to induction of p21 and p27, cyclin-dependent kinase inhibitors, 
and subsequent cell cycle arrest [62–64]. Activating AMPK using therapeutic drugs such 
as metformin, a mitochondrial complex I inhibitor, may be able to overcome breast 
cancer resistance to HER2 inhibitors while decreasing risk of cardiotoxicity [65] as well 
as inhibit growth and enhance radio-sensitivity of lung cancer cells [65,66].  
1.6 Tumor suppressor p53 
 The tumor suppressor protein p53 is encoded by the gene tumor protein p53 
(TP53) and in its active form is a tetramer of four identical subunits. Each subunit 
contains an N-terminal transactivation domain, a proline-rich region, a DNA-binding core 
domain, a regulatory domain contained within the C-terminal, a tetramerization domain 
and an unstructured basic domain [67]. Under healthy conditions, p53 levels are kept low 
within the cell and are regulated, through continuous degradation, by murine double 
minute 2 (MDM2) homologue. In a negative feedback loop, p53 increases MDM2 levels 
while MDM2 suppresses p53 activity (Figure 6) [68]. p53, expressed in all normal cells, 
acts to induce apoptosis (programmed cell death), modulate the cell cycle and aid in 
DNA repair. It is required in all cells for the maintenance of homeostasis and to signal the 
death of unhealthy or damaged cells.  
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Figure 6: Tumor Suppressor p53. Activation of tumor suppressor p53 leads to 
increased apoptosis however, loss of p53 function often occurs in cancer. 
 
The p53 protein becomes activated by phosphorylation in response to stresses 
including DNA damage by ultraviolet (UV) or ionizing radiation (IR), chemical agents, 
oxidative stress or deregulated oncogene expression [67]. Phosphorylation of p53 occurs 
by DNA damage response elements, such as DNA-dependent protein kinase (DNA-PK) 
which phosphorylates p53 at serines 15 and 37 and impairs the ability of MDM2 to 
inhibit p53 resulting in increased, activated p53 levels within the cell [68]. Activated p53 
binds DNA, initiating transcription of genes such as p21 and Bax, which induce cell cycle 
arrest to allow either repair and survival of the cell, or apoptosis. Tumor-associated 
mutations to the TP53 gene, typically single nucleotide substitutions in the coding 
sequence, occur often in cancers leading to dramatic defects in p53 function, reduced 
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
17 
 
tumor suppression and enhanced survival abilities of the cancer cells [69]. Mutant p53 
proteins are often not able to induce MDM2 and thus accumulate at high levels. 
Alternatively, in some tumors a loss of one or both p53 alleles (through a large 
chromosomal defect or a localized deletion) reduces the levels of wild-type p53 tetramers 
[70]. Tumors with enhanced Akt signaling show decreased apoptotic activity because Akt 
phosphorylates MDM2, allowing it to translocate into the nucleus and inhibit p53 levels 
[71]. AMPK is able to phosphorylate p53, activating it and thus, low levels of AMPK 
activity which are common in cancer cells result in decreased apoptosis (Figure 6) [72].  
Functional p53 has been shown to be necessary for DNA-damage induced 
apoptosis and sensitivity of cancer cells to ionizing radiation and the chemotherapy agent 
cisplatin [73]. Furthermore, ionizing radiation, which can induce G1 and G2 cell cycle 
arrest in proliferating cells, has been shown to be dependent on wild-type p53 function in 
various cancer cell lines [74]. Many new cancer treatments aim to restore endogenous 
wild-type p53 levels within the cell and enhance the function of existing wild-type p53 
thus resulting in apoptosis of cancerous cells and/or sensitization of cancer cells to 
cytotoxic therapies such as ionizing radiation.  
1.7 Hallmarks of carcinogenesis  
 Cancer cells are unique in their ability to mutate and grow uncontrollably by 
excessive proliferation and inhibition of apoptosis, as mentioned in previous chapters. 
The pathways mentioned in chapters 1.2 through 1.6 are highly implicated in cancer cell 
proliferation and survival and will be examined in this study however, there are other 
important hallmarks of cancer cells which contribute to the complexity of the disease and 
will be mentioned in this chapter. As normal cells transform into cancer cells, they 
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acquire a succession of these hallmark capabilities leading to a more aggressive and 
uncontrolled disease.  
1.7.1 Resisting cell death: extrinsic and intrinsic apoptotic mechanisms 
 Enhanced oncogene signaling resulting in excessive proliferation and DNA 
damage can lead to programmed cell death called apoptosis as mentioned in Chapter 1.6. 
There are several mechanisms by which a cell can trigger apoptosis including activation 
of tumor suppressor p53, as previously mentioned, or by intrinsic and extrinsic caspase 
signaling pathways (Figure 7). Caspases are cysteine aspartate-specific proteases, which 
can be rapidly activated. Initially synthesized as inactive pro-caspases, these molecules 
consist of a small subunit, large subunit and a long prodomain which enables them to 
interact with other molecules that regulate their activation. Following activation, the 
majority of the prodomain is cleaved, allowing them to proceed to activate effector 
caspases and initiate a response.  
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Figure 7: Intrinsic and extrinsic caspase cell signaling pathways are involved in 
regulating apoptosis and represent a different mechanism of programmed cell death from 
activation of tumor suppressor p53. 
 
 The intrinsic apoptotic pathway (Figure 7) does not involve receptors, but instead 
is activated in response to stimulation of the cell by a stressor such as DNA damage, 
ionizing radiation or a virus. Apoptosis through this pathway relies on the insertion of 
pro-apoptotic members of the Bcl-2 family, Bax/Bak, into the mitochondrial membrane, 
resulting in release of cytochrome c into the cytosol. Anti-apoptotic Bcl-2 family 
members such as Bcl-2 and Bcl-xL, are able to prevent cytochrome c release by binding 
and inhibiting Bax and Bak [75]. Cytochrome c released via the intrinsic pathway binds 
apoptotic protease activating factor-1 (Apaf-1) and together with deoxyadenosine 
triphosphate (dATP) recruits pro-caspase 9 to the complex. This multi-protein complex is 
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
20 
 
called the apoptosome and causes cleavage of pro-caspase 9 and thus activation of 
caspase 9, which activates caspase 3 and executes apoptosis [76]. In addition to 
cytochrome c, mitochondria release other peptides such as second mitochondrial activator 
of caspase (Smac/DIABLO) which promotes caspase 9 activation by neutralizing the 
inhibitory effects of inhibitor of apoptosis proteins (IAPs).  
The extrinsic apoptotic pathway (Figure 7) involves membrane bound death 
receptors, typically fibroblast associated antigen (Fas) receptor or tumor necrosis factor 
(TNF) receptor, which contain a cytosolic death domain (DD).  Upon activation by their 
respective extracellular ligands, the receptors form a death inducing signaling complex 
(DISC) whereby the DD of the receptor binds an adaptor protein, either Fas associated 
protein with death domain (FADD) or TNF receptor type 1-associated death domain 
protein (TRADD) respectively [77,78]. Caspase 8 is then recruited by the DISC, 
activated, and proteolytically activates downstream effector caspase 3 (by directly 
cleaving procaspase-3) which executes apoptosis [79]. Caspase 8 is also capable of 
cleaving Bid to its’ truncated form (tBid) which moves into the mitochondria and induces 
the release of cytochrome c. Once cytochrome c has entered into the cytosol it binds 
Apaf-1, activating caspase 9 which in turn activates caspase 3 which executes apoptosis 
[80]. Caspases execute apoptosis by cleaving their target proteins, thereby disabling 
important cellular processes and breaking down structural components of the cell [81].  
In cancer, tumors evolve a variety of strategies to try and limit or eliminate 
apoptosis, most commonly the loss of tumor suppressor p53. Alternatively, tumors may 
increase expression of antiapoptotic regulators (Bcl-2 or Bcl-xL), decrease expression of 
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proapoptotic factors (Bax or Bak) or inhibit the extrinsic ligand-induced death pathway 
[1]. 
1.7.2 Resisting cell death: autophagy and necrosis 
 
 Autophagy is a process which leads to the degradation of cellular proteins and 
cytoplasmic organelles to provide energy to the cell under conditions of stress or when 
the availability of external nutrient sources is limited. Many studies highlight the 
importance of autophagy in cancer however, it remains unclear whether autophagy 
suppresses tumorigenesis or provides cancer cells with a rescue mechanism in 
unfavourable conditions. Stress, resulting from oxidative damage or hypoxic conditions 
can damage cellular proteins and organelles. This damage triggers autophagy and 
elimination of the damaged components. Thus, in healthy cells autophagy acts as a 
homeostatic and survival-promoting mechanism [82]. 
 In cancer, some cells experience elevated metabolic stress from nutrient, oxygen 
and growth factor deprivation caused by inadequate blood supply resulting from deficient 
blood vessel formation (angiogenesis). This stress, compounded with the increased 
metabolic demand to drive cell proliferation, promotes autophagy and tumor survival. 
Tumor cells can progressively eat themselves (through autophagy) under prolonged 
stress, becoming less than one third their normal size and suppressing cell division and 
motility. These cells are considered dormant and inactive, but retain the capacity to return 
to their normal size and resume cell proliferation following restoration of normal growth 
factor conditions [83,84]. Thus, autophagy may act to promote survival of cancer cells. 
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 Alternatively, loss of autophagy can occur in cancer cells with certain mutations. 
Constitutive activation of the PI3K-Akt pathway (Chapter 1.3) causes unrelenting cell 
growth signals regardless of nutrient and growth factor availability. This leads to mTOR 
activation and subsequent inhibition of autophagy. Although constitutive growth signals 
drive cancer cell proliferation, these cancer cells are also rendered less able to induce 
autophagy in response to stressors and this can lead to metabolic fragility and increased 
likelihood of cell death [84]. Thus regulation of autophagy varies in each cancer cell and 
while it can act to promote cancer cell survival, it may also promote cancer cell fragility 
and represent an important therapeutic target. 
Many cancer treatments aim to reduce levels of autophagy to basal levels or 
induce apoptosis [83,85,86]. Tumor masses have heterogeneous areas of vessels and 
nutrient supply, and cancer cells residing in hypoxic tumor regions and undergoing 
autophagy are the cancer cells that resist chemo and radiotherapy[82]. This subpopulation 
of resistant cancer cells provides a potential target to improve cancer therapy. 
Alternatively, some cancer treatments such as nutrient starvation, radiotherapy and some 
cytotoxic drugs can induce elevated levels of autophagy which are thought to be 
protective for cancer cells, impairing rather than accentuating the stresses these 
anticancer treatments exert on cancer cells [82,83,87,88]. This represents an important 
issue with current cancer therapies and highlights the need for further investigation and 
development of new therapies.  
 Necrosis is a form of cell injury that results in the premature death of cells in 
living tissue. It is caused by factors external to the cell or tissue such as toxins, infection 
or trauma and is most often detrimental to the organism. Necrosis is often up-regulated 
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under conditions of stress however, unlike apoptosis it is not programmed, and it results 
in the release of the cell contents into surrounding tissue. Necrotic cell death results in the 
release of pro-inflammatory signals, recruiting immune inflammatory cells which, under 
normal conditions, remove associated necrotic debris. In cancer, evidence indicates that 
necrotic cells can be tumor promoting, causing increased inflammatory signals that can 
foster angiogenesis, cancer cell proliferation and invasiveness. These necrotic cells are 
also capable of releasing regulatory factors such as interleukins which can bind 
membrane receptors of viable neighbouring cells, stimulating proliferation and 
potentially facilitating neoplastic progression [89].  
1.7.3 Inducing angiogenesis 
Tumors, like normal tissues, require nutrients, oxygen and the ability to evacuate 
metabolic wastes and carbon dioxide. They do so by developing their own vasculature 
through a process known as angiogenesis, the sprouting of new vessels from existing 
ones. During tumor progression, an “angiogenic switch” is almost always activated and 
remains on, causing normally quiescent vasculature to sprout new vessels that help 
sustain expanding neoplastic growths [90]. Some regulators of angiogenesis, including 
stimulatory vascular endothelial growth factor-A (VEGF-A) and inhibitory 
thrombospondin-1 (TSP-1) are signaling proteins which bind to cell-surface receptors 
displaced by vascular endothelial cells [91,92]. In addition, members of the fibroblast 
growth factor (FGF) family have been implicated as proangiogenic factors when their 
expression is chronically up-regulated [91].  
The VEGF gene encodes ligands involved in orchestrating new blood vessel 
growth during embryonic and postnatal development, and then in homeostatic survival of 
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epithelial cells in adults. VEGF signals through 3 receptor tyrosine kinases (VEGF-1-3) 
and its gene expression can be up-regulated by hypoxia and oncogenic signals [93,94]. 
Additionally, VEGF ligands can be sequestered in the extracellular matrix in latent forms 
that are subject to release and activation by extracellular matrix-degrading proteases such 
as MMP-9 [95]. TSP-1, a key counterbalance in the angiogenic switch, also binds 
transmembrane receptors on endothelial cells and evokes suppressive signals to 
counteract proangiogenic stimuli [96]. Historically, angiogenesis was envisioned to be 
important only when rapidly growing large tumors had formed, but more recent data 
indicate that angiogenesis also contributes to the microscopic premalignant phase of 
neoplastic progression [1].  
1.7.4 Activating invasion and metastasis   
 Local invasion and distant metastasis are reflections of advanced, high grade 
malignancies which have developed alterations in their shape as well as in their 
attachment to other cells and to the extracellular matrix. The loss of E-cadherin, a key 
cell-to-cell adhesion molecule, by cancer cells through down-regulation or mutation is an 
alteration commonly involved in invasion and metastasis [97,98]. Adhesion molecules 
which are normally associated with the cell migration that occurs during embryogenesis 
and inflammation, such as N-cadherin, are often up-regulated in invasive neoplastic 
environments. Beyond the gain and loss of such cell-cell/matrix attachment proteins, the 
master regulators of invasion and metastasis are largely unknown [98]. Generally, the 
process begins with local invasion of surrounding tissues, followed by entry of cancer 
cells into nearby blood and lymphatic vessels which carry the cells through the body until 
they escape into the parenchyma of distant tissues and form small nodules of cancer cells 
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which will grow into metastatic lesions [1]. Epithelial-mesenchymal transition (EMT) has 
become prominently implicated as a means by which transformed epithelial cells can 
acquire the abilities to invade, to resist apoptosis and to metastasize [99–101]. This EMT 
program can be activated transiently or stably, and to different degrees, by cancer cells 
during invasion and metastasis [1]. The process of EMT is orchestrated by a combination 
of transcription factors which act to evoke loss of adheren junctions, conversion from 
epithelial to mesenchymal morphology, expression of matrix-degrading enzymes, 
increased motility and heightened resistance to apoptosis – all traits implicated in the 
process of invasion and metastasis [1]. Taken together, these cancer hallmarks highlight 
the diversity of the disease and the importance of finding new therapies and prevention 
strategies which target deregulated cancer cell signaling.  
1.8 Natural compounds in cancer therapy 
 Many pharmaceutical agents have been discovered by screening natural products 
from plants. Some of these drugs such as the chemotherapeutics etoposide, isolated from 
the mandrake plant and Queen Anne’s lace, and paclitaxel and docetaxel, isolated from 
the wood and bark of the Nyssaceae tree, are currently successfully employed in cancer 
treatment [102]. The exploration into natural products offers great opportunity to evaluate 
new chemical classes of anticancer agents as well as novel and potentially relevant 
mechanisms of action. Many labs, including ours have shown metformin, a drug derived 
from the lilac, has anticancer properties [66]. In addition, the polyphenol resveratrol, 
found in high concentrations in wine, has been shown to have anticancer effects in vitro 
[103] and in vivo [104]. Rosemary extract, which is rich in polyphenols, has been shown 
in our lab to increase glucose uptake in rat muscle cells and act on signaling pathways 
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which are highly implicated in cancer. Thus, further investigation of rosemary’s potential 
anticancer effects are warranted.   
1.9 Anticancer effects of rosemary extract (Rosmarinus Officinalis L.)  
The plant Rosmarinus Officinalis L. a member of the mint family Lamiaceae, is 
native to the Mediterranean region and has many culinary and medicinal uses. The 
rosemary plant grows quite easily and in a variety of climates as long as sunlight and 
proper drainage is present, and temperatures are above freezing. The main polyphenols 
found in rosemary extract include the diterpenes carnosic acid (CA), rosmarinic acid 
(RA) and carnosol (CN) [105]. Rosemary extract and some of its polyphenol components 
have recently been explored and found to exert potent anticancer effects summarized in 
the following sections. Findings are sorted by cancer cell type and are in chronological 
order (earliestmost recent). 
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1.9.1 Anticancer effects of rosemary extract: in vitro studies 
Table 1: Anticancer effects of RE in vitro: colon cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
CaCo-2  
 
0.1-30µg/mL (3-
24h) 
↓ cell colony formation. 
Long and short term antioxidant 
effects. 
↓ H2O2-
induced DNA 
strand breaks 
& oxidative 
damage.  
↓ visible light-
induced 
oxidative 
damage  
[106] 
     
SW480  
 
31.25-500 µg/mL 
(48h) 
↓ cell proliferation. 
Cytotoxic above 250 µg/mL. 
IC50 ~ 71.8 µg/mL  
 
 [107] 
     
SW620,  
DLD-1  
 
20-110 µg/mL 
(24-48h) 
↓ cell proliferation 
IC50 36.4 & 34.6 µg/mL 
Effect on 5-FU sensitive and resistant 
cells 
↑ apoptosis 
↓ cell transformation 
Modulates 
TYMS & 
TK1. 
↑ PARP 
cleavage. 
[108] 
     
SW620, 
 DLD-1  
 
0-120 µg/mL 
(48h)   
 
↓ cell viability  
IC50  25µg/mL 
 
↑ PARP 
cleavage. 
↑GCNT3.  
↓miR-15b 
gene 
expression. 
[109] 
 
 CA (10-30% w/w) 
(48h) 
↓ cell viability ↑GCNT3. 
↓miR-15b 
gene 
expression. 
 
 CN (1-3.8% w/w) 
(48h) 
↔ cell viability 
Potentiates CA-induced ↓ cell 
viability 
 
  
H2O2 (hydrogen peroxide), 5-FU (fluorouracil), TYMS (thymidylate synthase), TK1 (thymidine kinase 1), 
PARP (poly ADP ribose polymerase), GCNT3 (glucosaminyl (N-acetyl) transferase 3), miR-15b 
(microRNA-15b) 
  
Several in vitro studies using colon cancer cell lines have shown rosemary extract 
(RE) to exhibit anticancer properties. Exposure of CaCo-2 colon cancer cells to RE 
drastically decreased colony formation at 30 µg/mL (24h) [106]. Yi (2011) examined the 
anti-tumorigenic effect of several culinary and medicinal herbs on SW480 colon cancer 
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cells and found RE to significantly decrease cell growth at a concentration of 31.25 
µg/mL (48h), with an IC50 of approximately 71.8 µg/mL [107]. Cell growth of SW620 
and DLD-1 colon cancer cells was significantly inhibited by RE at 30 µg/mL (48h), with 
an IC50 as low as 34.6 µg/mL. RE was also able to inhibit colony formation in soft agar 
and thus may be able to prevent cell transformation. Furthermore, RE enhanced the 
inhibitory effects of the chemotherapeutic drug 5-fluorouracil (5-FU) on proliferation and 
sensitized 5-FU resistant cells [108]. 
In SW620 and DLD-1 colon cancer cells RE was able to inhibit cell viability 
dose-dependently resulting in significant inhibition at concentrations as low as 20 µg/mL, 
and an IC50 around 25 µg/mL (48h). This study used 5 different RE’s, containing 
increasing levels of carnosol (CN:1-3.8% w/w) and carnosic acid (CA: 10-30% w/w). 
Inhibition of cell viability was correlated with increasing CA content. Furthermore, CA 
alone (at doses found in RE) decreased cell viability and this effect was potentiated by 
the addition of CN (at doses found in RE). However, the inhibition seen using RE was 
greater than the response seen with CA or CN alone or in combination [109]. This 
supports the use of total RE over its individual components. These studies provide 
evidence for the role of RE as an anticancer agent in colon cancer cells, capable of 
consistently inhibiting cell growth and viability at relatively low concentrations in the 20-
100 µg/mL range.  
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Table 2: Anticancer effects of RE in vitro: pancreatic cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
     
RINm5F rat 
insulinoma  
 
12-100 µg/mL 
(24-48h) 
↓ cell proliferation  
↓ cell viability  
↑ apoptosis 
 
↑ nitrate 
accumulation.  
↑ TNFɑ 
production. 
[110] 
 CA (12-100 
µg/mL) 
(24-48h) 
 
↓ cell viability 
 
  
MIA-PaCa-2, 
PANC-1   
 
0-120 µg/mL 
(48h)   
 
↓ cell viability  
 
↑ PARP-
cleavage 
[109] 
 
 CA (10-30% w/w) 
(48h) 
 
↓ cell viability 
 
  
 CN (1-3.8% w/w) 
(48h) 
↔ cell viability 
Potentiates CA-induced ↓ cell 
viability 
 
  
TNFɑ (tumor necrosis factor), PARP (Poly ADP ribose polymerase) 
 
In rat RINm5F insulinoma cells, RE significantly inhibited cell proliferation at 25 
µg/mL (24h), viability at 12 µg/mL (24h) and increased apoptosis at 25 µg/mL (24h). To 
examine the role of the main compound in RE and determine its involvement in these 
anticancer effects, CA at 50 µg/mL (48 h) was tested and found to significantly decrease 
cell viability by 75%. The authors suggested that CA could be involved in RE’s 
mechanism of cell viability inhibition [110]. However, 50 µg/mL (150µM) of carnosic 
acid is a very high concentration, not comparable to the amount that would be found in 
RE. At the highest concentration of RE used in this study of 100 µg/mL, and given that 
the content of CA was measured to be 177.3 ± 9.71mg/g dry extract, the maximum 
concentration of CA (MW 332.4) would be only 17.7 µg/mL (53 µM). Thus, the 
statement that CA could be involved in RE’s mechanism should be taken with caution.  
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Exposure of pancreatic cancer cells PANC-1 and MIA-PaCa-2 to RE containing 
increasing concentrations of carnosol (CN: 1-3.8% w/w) and carnosic acid (CA: 10-30% 
w/w) resulted in significant inhibition of cell viability with an IC50 of 50 µg/mL (48h) 
and 30 µg/mL (48h) respectively. The RE containing 25.66% w/w CA (sub-max) caused 
maximal inhibition compared to other RE’s in PANC-1 cells, significantly inhibiting cell 
viability to approximately 60% at 40 µg/mL (48h) [109]. Taken together, these studies 
suggest a role for RE to inhibit pancreatic cancer cell viability and proliferation, and 
induce apoptosis at relatively low concentrations in the 10-100 µg/mL range. They also 
suggest that CA may play a role in RE’s anticancer mechanism however, further research 
needs to be done investigating RE’s polyphenol components. 
Table 3: Anticancer effects of RE in vitro: breast cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
MCF-7 (ER+) 40mg RE powder 
filter (inserted into 
cigarette) (2h)  
 ↓ BP levels 
& associated 
DNA adduct 
formation. 
[111] 
MCF-7 (ER+), 
MDA-MB-468 
(TN)  
 
0.1-20% (5-120h)  IC50 ~90 µg/mL & 26.8 µg/mL 
 
 [112] 
MCF-7 (ER+), 
MDA-MB-231 
(TN) 
 
6.25-50 µg/mL 
(48h)  
↓ cell viability 
IC50 ~20.42 µg/mL  
 
 [113] 
 CA 6.25-50 
µg/mL (48h) 
 
↓ cell viability 
 
  
 RA 6.25-50 
µg/mL (48h) 
 
↑ cell viability 
 
  
SK-BR-3 
(HER2+), 
UACC-812 
(HER2+),  
T-47D (ER+), 
MCF-7 (ER+), 
MDA-MB-231 
(TN) 
10-120 µg/mL 
(48h)   
↓ cell viability  
Enhanced effect of chemotherapeutics 
↑ apoptosis 
↓ cell transformation 
↑ FOS levels 
↑ PARP 
cleavage 
↓ HER2  
↓ ERBB2 
↓ ERɑ 
receptor  
[114] 
 
BP (benzopyrene), Fos (FBJ murine osteogenic sarcoma virus). PARP (poly ADP ribose polymerase), 
HER2 (human epidermal growth factor receptor 2), ERBB2 (HER2/neu gene), ERɑ (estrogen receptor ɑ) 
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Breast cancer can be classified under three subtypes based on the sensitivity of the 
tumors to chemotherapeutic agents. The subtypes are i) estrogen receptor positive (ER+), 
which express ERɑ and therefore respond to estrogens; ii) human epidermal growth 
factor receptor 2 positive (HER2+) which overexpress HER2 and can be either ER+ or 
ER-; iii) triple negative (TN) which lack expression of ERɑ, progesterone receptor and 
HER2. One study used MCF-7 (ER+) breast cancer cells and a cigarette smoke solution 
(in PBS) collected from a cigarette with or without 40mg RE added to the filter. The 
control used in this experiment was cells stimulated with 2.5µM benzopyrene for 12-18 
hours and exposed to 1:19 v/v cigarette smoke solution for 2 hours without an RE filter. 
In the experimental group, the presence of RE in the filter lead to considerably reduced 
benzopyrene levels and associated DNA adduct formation [111]. 
 RE  inhibited cell proliferation in breast cancer cells with an IC50 of 90 µg/mL 
and 26.8 µg/mL in MCF-7 (ER+) and MDA-MB-468 (TN) cell lines respectively [112]. 
In a similar study, dose-dependent inhibition of cell viability by 6.25-50 µg/mL (48h) RE 
was seen in MDA-MB-231(TN) and MCF-7 (ER+) breast cancer cells and MCF-7 cells 
had an IC50 of ~24.02 µg/mL. There is a large discrepancy between the IC50s of the 
MCF-7 cell line in these studies, which may be attributed to the different extraction 
methods used; supercritical CO2 [113] and ethanol extraction [112]. Carnosic acid (CA) 
and rosmarinic acid (RA) were also examined in breast cancer cells. CA decreased cell 
viability dose-dependently from 6.25-50 µg/mL in both cell lines, while RA resulted in 
enhanced cell viability [113]. 
 The effects of RE at 0-120 µg/mL (48h) were explored in all three breast cancer 
subtypes, ER+, HER2+ and TN. RE caused dose-dependent inhibition of cell viability in 
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all subtypes of breast cancer cells. Furthermore RE enhanced the effectiveness of the 
monoclonal antibody (mAb) trastusumab and the chemotherapeutic drugs tamoxifen and 
paclitaxel, used in the treatment of breast cancer [114]. Thus, although it has been shown 
that RE as well as its main component CA are capable of reducing cell proliferation and 
viability within the 10-100 µg/mL range in all breast cancer subtypes, the mechanisms by 
which it does so remain unclear and require further exploration. 
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Table 4: Anticancer effects of RE in vitro: leukemia  
Cancer Cell Dose/Duration Findings Mechanism Reference 
WEHI-3B D 
murine & 
HL60, U937 
human 
myeloid 
leukemia  
 
RE (10µM 
equivalent of CA)  
(48-96h) 
Potentiated following effects of VDA: 
↓ cell proliferation  
↑ cell cycle arrest  
↑ cell differentiation 
↑ apoptosis  
 
↑ G1 phase [115] 
 CA 10µM  
(48-96h) 
Potentiated following effects of VDA: 
↓ cell proliferation 
↑ cell differentiation 
↑ apoptosis 
↑ cell cycle arrest  
 
↑ G1 phase  
Mouse RAW 
264.7 
macrophages 
& HL60, K562 
human 
leukemia 
 
0.1-20% (5-120h)  ↓ cell proliferation 
IC50 ~ 18.76 µg/mL & 33.5 µg/mL  
↑ cell differentiation  
↓ LPS-stimulated (LS) antioxidant 
activity 
↓ (LS) NO  
↑ antiox. 
activity 
↔ basal 
TNFɑ, IL-
1β, iNOS or 
COX2  
↓ (LS) IL-1β 
& COX2 
[112] 
     
WEHI-3B D 
murine 
myeloid 
leukemia 
 
RE (10µM 
equivalent of CA)  
(48-96h) 
Potentiated following effects of VDA: 
↑ cell differentiation 
↓ cell viability 
↓ cell proliferation  
  
↓ ROS 
↑ antiox. 
↑ NADP(H)-
quinone 
reductase  
 
[116] 
 CA 10µM  
(48-96h)  
Potentiated following effects of VDA: 
↑ cell differentiation 
↓ cell viability  
↓ cell proliferation  
↓ ROS 
↑ antiox. 
↑ NADP(H)-
quinone 
reductase  
 
 
K-562 
 
6.25-50 µg/mL 
(48h)  
↓ cell viability 
 IC50 ~12.50 µg/mL 
 
 [113] 
 CA 6.25-50 
µg/mL (48h) 
 
↓ cell viability   
 RA 6.25-50 
µg/mL (48h) 
 
↑ cell viability   
K-562, U937 50 µg/mL (0-96h) 
 
↓ cell proliferation   
 
↓ AKT1  
↑  Rb2 
↔ ERK2  
 
[117] 
 0.2mM RA (48h) Not tested on proliferation ↔ AKT1  
↔ ERK2  
 
VDA (vitamin D analogue), LPS (lipopolysaccharide), NO (nitric oxide), TNFɑ (tumor necrosis factor ɑ) , 
IL-1β (interleukin 1β) , iNOS (inducible nitric oxide synthase), COX2 (cyclooxygenase 2), ROS (reactive 
oxygen species), NADP(nicotinamide adenine dinucleotide phosphate), Rb2(retinoblastoma-related gene 2) 
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Vitamin D analogues (VDA) are commonly used in clinical differentiation 
therapy of acute myeloid leukemia (AML) to attempt to restore a defect in the capacity of 
myeloid progenitor cells to mature into non-replicating adult cells. However, 
pharmacologically relevant doses have been found to result in many adverse events such 
as hypercalcemia and attempts to circumvent these adverse events have been 
unsuccessful. RE containing 10µM equivalent of CA, or 10 µM  CA alone (96h) 
potentiated the ability of vitamin D derivatives to inhibit cell viability and proliferation, 
and increase differentiation of WEHI-3BD murine leukemic and human HL-60 leukemic 
cells [115,116]. This RE (48-96h) was also found to potentiate the increased apoptosis 
and cell cycle arrest seen by VDAs  [115]. A study examining the human leukemia HL-
60 and K-562 cell lines and the murine RAW264.7 macrophage/monocyte cell line found 
significant inhibition of proliferation (48-96h) and the IC50 of the human HL-60 and K-
562 cell lines to be 0.14% (18.76 µg/mL) and 0.25% (33.5 µg/mL) respectively. At 0.1% 
(13.4 µg/mL;72h) RE significantly increased differentiation in the HL-60 cell line [112]. 
RE inhibited viability at 50 µg/mL (48h) in K-562 leukemia cells. CA at concentrations 
of 6.25-50 µg/mL (48h) significantly inhibited K-562 cell viability while RA was 
ineffective [113]. Similar effects of RE (50 µg/mL; 24h) were reported by others that lead 
to decreased cell proliferation in K-562 cells [117].  
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Table 5: Anticancer effects of RE in vitro: prostate cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
     
DU145, PC3 
 
6.25-50 µg/mL 
(48h)  
↓ cell viability 
IC50 ~8.82 µg/mL 
 
 [113] 
 CA 6.25-50 
µg/mL (48h) 
 
↓ cell viability   
 RA 6.25-50 
µg/mL (48h) 
 
↔ cell viability   
LNCaP, 22RV1 
 
10-50 µg/mL (24-
48h) 
*RE standardized 
to 40% CA 
↓ cell proliferation 
↑ cell cycle arrest  
↑ apoptosis 
modulates endoplasmic reticulum 
stress proteins. 
↑CHOP  
↓ PSA 
production 
↑ Bax 
↑ cleaved-
caspase 3 
↓androgen 
receptor 
expression  
[118]  
CHOP (C/EBP homologous protein), PSA (prostate specific antigen), Bax (Bcl-2 associated X protein)  
  
RE (6.25-50 µg/mL; 48h) inhibited viability of DU145 prostate cancer cells. 
Furthermore, CA at 6.25 µg/mL(48h) inhibited cell viability of both DU145 and PC3 
cells, and RA had no effect on cell viability [113]. In agreement with these data, 
significant inhibition of LNCaP and 22RV1 prostate cancer cell proliferation and 
viability, and an induction of apoptosis were seen with RE (50 µg/mL standardized to 
40% CA; 24-48h). RE was able to combat the enhanced prostate specific antigen (PSA) 
levels measured in cell culture media, indicative of prostate cancer, inhibiting levels to 
less than a fifth of what was seen in the control group. Correspondingly, levels of the 
androgen receptor, to which PSA binds, were significantly decreased by 50 µg/mL RE 
[118]. Thus, RE is capable of inhibiting cell viability and proliferation, and inducing 
apoptosis in both androgen sensitive and insensitive cell lines, making it an attractive 
potential chemotherapeutic with diverse applications.  
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Table 6: Anticancer effects of RE in vitro: ovarian cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
A2780, 
A2780CP70 
(cisplatin-
resistant)  
 
0.05 - 0.25% (24-
48h) 
 
 
↓ cell proliferation  
Enhanced sensitivity of cisplatin -
resistant cell lines. 
↑apoptosis  
↑ cell cycle arrest 
Modulates expression of apoptotic 
genes. 
  
↓ P-glyco 
protein 
↑ cyt c gene 
↑ hsp70 gene 
[119] 
 CA 2.5-10 µg/mL 
(48h) (7.5-30µM) 
 
↓ cell proliferation 
Enhanced sensitivity of cisplatin-
resistant cells 
 
  
 RA 2.5-10 µg/mL 
(48h) 
 
↓ cell proliferation 
Enhanced sensitivity of cisplatin-
resistant cells 
 
  
 CN 2.5-10 µg/mL 
(48h) 
 
↓ cell proliferation 
Enhanced sensitivity of cisplatin-
resistant cells 
  
cyt c (cytochrome C), hsp70 (heat shock protein 70) 
 
Table 7: Anticancer effects of RE in vitro: liver cancer  
Cancer Cell Dose/Duration Findings Mechanism Reference 
Hep-3B 
 
6.25-50 µg/mL 
(48h)  
↓ cell viability 
 IC50 ~22.88 µg/mL 
 
 [113] 
 CA 6.25-50 
µg/mL (48h) 
 
↓ cell viability   
 RA 6.25-50 
µg/mL (48h) 
↔ cell viability   
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Table 8: Anticancer effects of RE in vitro: lung cancer  
Cell Dose/Duration Findings Mechanism Reference 
NCI-H82 
(small cell) 
 
6.25-50 µg/mL 
(48h)  
↓ cell viability 
IC50 ~24.08  
 
 [113] 
 CA 6.25-50 
µg/mL (48h) 
 
↓ cell viability   
 RA 6.25-50 
µg/mL (48h) 
 
↔ cell viability   
V79 hamster 
normal lung 
fibroblasts 
0.1-30 µg/mL 
(3-24h) 
Cytotoxic to cells at 30 µg/mL 
(24h) 
Long and short term antioxidant 
effects 
↓ H2O2-
induced 
DNA strand 
breaks & 
oxidative 
damage. 
↓ visible-
light induced 
oxidative 
damage 
[106] 
 
 Exposure of A2780 ovarian cancer cells to 0.08% (48h) RE containing media 
resulted in significant inhibition of proliferation and induction of apoptosis and cell cycle 
arrest. However, it should be noted that 0.08% RE corresponds to 800 µg/mL, a 
concentration far greater than those used in any other cancer cell lines. Cisplatin is a 
chemotherapeutic agent used often in cancer treatment however, as with many 
chemotherapeutics, patients often develop a resistance. At 0.08% RE enhanced the 
sensitivity of A2780 and cisplatin-resistant A2780CP70 cell lines to growth inhibition by 
cisplatin treatment, suggesting that RE may be of use in combination with cisplatin or 
potentially other chemotherapeutic drugs in patients who have developed an acquired 
resistance. Furthermore, the individual components of RE: CA, RA and CN at low 
concentrations (2.5, 5, 5 µg/mL respectively; 48h) alone were able to inhibit cell 
proliferation and enhance sensitivity of cisplatin-resistant cells to inhibition of 
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proliferation by cisplatin. [119]. This indicates that the beneficial effects of RE may be 
due to these polyphenols.  
 In human liver Hep-3B and small cell lung NCI-H82 carcinoma cells, RE at 6.25-
50 µg/mL (48h) dose-dependently decreased cell viability with an IC50 of 22.88 µg/mL 
and 24.08 µg/mL in each cell line respectively. Additionally, CA at 6.25 µg/mL (48h) 
inhibited cell viability while RA had no effect [113]. In a V79 normal hamster lung 
fibroblast cell line RE was cytotoxic at 30 µg/mL (24h) [106]. The cytotoxicity of RE in 
normal fibroblasts raises questions about its potential as a successful treatment option 
however, further research is required to fully examine the cytotoxicity issue in normal 
tissues. All of the above mentioned studies indicate that RE shows promising anticancer 
effects and this warrants further research to elucidate the mechanisms employed by RE. 
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1.9.2 Anticancer effects of rosemary extract: in vivo animal studies  
Table 9: Anticancer effects of RE in vivo  
Animal Model Dose/Duration Findings Mechanism Reference 
SW620 colon 
xenograft  
(nude mice) 
 
1mg/mL in 
drinking water 
(32-35d) ad 
libitum  
 
↓ tumor size  
 
↓ miR-15b in 
plasma 
[109] 
 
22RV1 
prostate 
xenograft 
(athymic nude 
mice) 
 
100mg/Kg/day in 
olive oil, orally 
(22d) 
↓ tumor volume (induces apoptosis) ↓ androgen 
receptor 
expression   
↓ PSA 
↑ CHOP  
[118] 
Myeloid 
leukemia 
inoculated 
mice  
 
1% RE w/w in 
food ad libitum 
(29d) 
↓ tumor volume  
↓ tumor incidence 
Potentiated VDA ability to ↓ tumor 
volume 
 [115] 
Myeloid 
leukemia 
inoculated 
mice  
 
4% w/w in food ad 
libitum. 
(15w) 
RE alone ↔ median survival time 
RE+VDA ↑ median survival time 
 
↓ WBC [116] 
DEN-induced 
liver cancer 
(F344 rats) 
 
100mg/Kg/day RE 
intragastrically 
(5d) 
Injected i.p with 
20mg/Kg DEN on 
day 4. 
Fed normal diet 
until week 3 
(underwent partial 
hepatectomy).  
 
↑ antioxidant activity ↓ GST 
positive foci 
[120] 
Swiss mice 
exposed to γ-
IR (liver) 
 
6Gy γ-IR (once) 
followed by 
1000mg/Kg/day 
RE orally (5d) 
Delayed onset of IR-induced 
mortality 
Attenuated negative IR effects 
Protective effect on liver & blood 
 
↓ LPx levels 
↑ GSH levels  
[121] 
DMBA-
induced skin 
cancer (nude 
mice) 
 
1000 mg/Kg/day 
RE orally in water 
or by gavage 
(15w)  
 
↓ tumor number 
↓ tumor incidence 
↓ tumor burden 
↓ tumor yield  
↑ latency period  
 
↓ LPx levels 
↑ GSH levels 
 
[122] 
 
DMBA-
induced skin 
cancer (nude 
mice) 
 
500mg/Kg/day RE 
orally in water or 
by gavage (15w)  
 
↓ tumor number 
↓ tumor diameter  
↓ tumor weight  
  
↓ LPx levels 
↑ GSH levels 
[123] 
 
miR-15b (microRNA 15b), PSA (prostate specific antigen), CHOP (C/EBP homologous protein), VDA 
(vitamin D analogue), WBC (white blood cell), GST (glutathione S transferase), IR (ionizing radiation), 
LPx (lipid peroxidase), GSH (glutathione), DEN (diethylnitrosamine), DMBA (dimethylbenzanthracene)   
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A limited number of studies have examined the effects of RE administration on 
tumor growth in animals in vivo. Administration of RE (1mg/mL) in the drinking water 
ad libitum for 32-35 days resulted in a significant decrease in tumor size in nude mice 
xenografted with SW620 colon cancer cells [109]. Similarly, a significant reduction in 
tumor volume was seen in mice xenografted with 22RV1 prostate cancer cells by RE 
(100mg/Kg/day) which was administered, dissolved in olive oil for 22 days [118].  
 In WEHI-3BD myeloid leukemia xenografted mice fed 1% w/w RE in their food 
ad libitum (29d), investigators noted a significant decrease in both tumor volume and 
incidence. Vitamin D analogues (VDA) are commonly used in the treatment of leukemia, 
and RE showed an additive effect when combined with VDAs in these mice by further 
decreasing tumor volume [115]. Similarly, in WEHI-3BD xenografted mice administered 
RE (4% w/w in food) for up to 15 weeks combined with VDAs, median survival time 
was significantly increased and white blood cell count in the leukemic mice decreased to 
levels comparable to those seen in the control group of healthy mice [116]. 
 In a diethylnitrosamine (DEN)-induced liver cancer model in F344 rats, RE at 
100mg/Kg/day (5d) was administered intragastrically for 5 days, with an intraperitoneal 
(i.p) injection of DEN on day 4. From this point, rats were fed a normal diet for 3 weeks 
until undergoing partial hepatectomy. Examination of liver tissue suggested RE may 
exert some protective antioxidant effects [120]. In accordance with this, use of Swiss 
mice exposed to 6 Grays (Gy) ionizing radiation (IR) in their liver once, followed by 
treatment with 1000mg/Kg RE fed orally, daily for 5 days suggested protective, 
antioxidant activity by RE. A delayed onset of IR-induced mortality and attenuated 
increases in glycogen and protein levels were seen in livers of mice exposed to IR and fed 
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RE, compared to IR-exposed mice not fed RE [121]. Taken together, these studies 
suggest a role for RE inhibiting chemical- or IR-induced carcinogenesis by exerting 
protective, antioxidant effects on healthy tissues. Thus, RE may display radioprotective 
effects which would benefit healthy tissue during radiation treatment.  Caution should be 
taken however, due to the high concentration (1000mg/Kg) used by Soyal (2007) [121] 
which is at least 10 times greater than what has been found to exert potent anticancer 
effects in other studies. 
 Using a 7,12-dimethylbenz(a)anthracene (DMBA)-induced skin cancer nude 
mouse model, RE (1000 mg/Kg/day; 15w) administered orally in water resulted in a 
significant decrease in tumor number, incidence and burden, and an increase in latency 
period compared to control mice treated with DMBA only [122,123]. Furthermore, this 
group used 500mg/Kg/day RE and again saw a significant decrease in tumor number, 
diameter and weight compared to DMBA-only treated mice [123]. One group of mice, 
which were administered RE for 7 days prior to the first application of DMBA, showed a 
50% reduction in tumor growth compared to the DMBA-only treated mice [123]. Taken 
together, although the concentrations used in these studies are high, they provide 
evidence of RE’s antioxidant effects in vivo, and its significant ability to inhibit tumor 
growth and prevent carcinogenesis by chemicals.  
The large variability in concentrations of RE used in these in vivo animal studies 
highlights the need for systematic investigation regarding effective concentrations of RE. 
Moreover, further research on RE’s mechanism in vitro and in vivo is necessary before 
conclusions can be made on its’ potential as an effective anticancer agent.  
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1.10 Mechanisms of anticancer effects of rosemary extract: in vitro studies 
 Many studies have examined the anti-proliferative and colony forming abilities of 
RE in vitro in colon [106–108], pancreas [110], breast [112,114], leukemia [112,115–
117], prostate [118] and ovarian [119] cancer cell lines however, little is known 
concerning the underlying mechanism. RE was shown to have an inhibitory effect on 
ATK1 mRNA and protein expression, a protein involved in the PI3K/Akt survival 
signaling pathway, in a leukemic cell line [117] however, no measure of Akt activity was 
mentioned. No effect on ERK2 protein levels, involved in cell proliferation and 
differentiation, were seen in these cells. Cell cycle arrest prevents further division by 
proliferating cells and RE was shown to induce cell cycle arrest in a number of cancer 
cell lines by increasing the proportion of cells arrested in the G1 phase [115] and 
increasing retinoblastoma-related gene 2 (Rb2) [117] which regulates entry into cell 
division. 
 The viability of various cancer cell lines was shown to be significantly inhibited 
by treatment with RE which many studies attributed to enhanced apoptosis and cell death. 
Increased poly ADP ribose polymerase (PARP) cleavage, which is an established 
indicator of enhanced apoptosis, was seen in colon [108,109], pancreas [109] and breast 
[114] cancer cell lines following treatments with RE.  Alternatively, RE enhanced nitrate 
accumulation (ie increased nitric oxide production) and TNFɑ production in pancreatic 
cancer cells [110], indicative of enhanced cell death capabilities and nitric oxide-induced 
apoptosis. In ovarian cancer cells [119] enhanced apoptosis was associated with increased 
gene expression of mitochondrial-regulated apoptosis proteins cytochrome c, involved in 
the electron transport chain, and heat shock protein 70 (hsp70) which is involved in 
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protein folding and protecting the cell from heat stress and toxic chemicals. Other 
mechanisms of apoptosis by RE include enhanced protein expression of pro-apoptotic 
Bax and cleaved caspase-3, increased expression of binding immunoglobulin protein 
(BiP) and CCAAT/-enhancer-binding protein homologous protein (CHOP) proteins 
which induce endoplasmic reticular stress, and the unfolded protein response leading to 
reduced androgen receptor expression and apoptosis in prostate cancer cells [118]. 
Interestingly, in normal prostate epithelial cells RE treatment resulted in a decrease in 
endoplasmic reticulum stress related protein PRKR-like endoplasmic reticulum kinase 
(PERK), suggesting RE selectively induces endoplasmic reticular stress in prostate 
cancer cells but spares normal prostate cells [118]. Similarly, in breast cancer cells [114] 
RE decreased expression of estrogen receptor ɑ (ERɑ) in the ER+ subtype and human 
epidermal growth factor receptor 2 (HER2) in the HER2+ subtype, and it was suggested 
the decreased receptor expression was correlated with enhanced apoptosis in these cell 
subtypes. Correspondingly, increased levels of Fos, an oncogenic transcription factor, 
were detected in ER+ and HER2+ cell lines, and this event is thought to precede 
apoptosis and correspond to the PARP-cleavage seen in these cells. Although RE was 
also capable of inducing anticancer effects in triple negative (TN) breast cancer cells, its 
mechanism has yet to be elucidated [114]. Thus, it can be concluded that apoptosis is an 
important mechanism of RE in cancer however, not all cell lines may rely on the same 
method of apoptosis.  
 Antioxidants are molecules which scavenge harmful free radicals, protecting cells 
from oxidative DNA damage and potentially death. RE has been shown to exert 
antioxidant effects in colon [106], breast [111], and leukemia [112,116] cell lines. Colon 
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cancer cells pretreated with RE followed by treatment with hydrogen peroxide, often 
used in cell culture to induce oxidative DNA damage, showed reduced DNA double-
strand breaks and oxidative damage compared to control cells treated with hydrogen 
peroxide only. Similarly, RE reduced oxidative damage induced by methylene blue 
(oxidizes purines) in these cells [106]. RE treatment resulted in increased levels of 
antioxidants and NAPD(H)-quinone reductase (oxidoreductase involved in the transfer of 
electrons from a reduced molecule to an oxidized molecule) which decreased reactive 
oxygen species (ROS) levels, and inhibited lipopolysaccharide (LPS)-stimulated 
production of the free radical nitric oxide (NO) in leukemia cell lines [112,116]. In an in 
vitro model of cigarette smoking, the use of an RE containing cigarette filter considerably 
reduced benzopyrene (carcinogen) levels and associated DNA adduct formation in breast 
cancer cells [111]. The use of RE for its antioxidant properties is beneficial as a 
preventative measure in cancer therapy. Antioxidants work to restore damaged DNA 
back to normal and protect the cell from further damage thus, preventing the potential 
mutation into a cancer cell and subsequent tumor formation.  
 In addition to the antiproliferative, apoptotic and antioxidant mechanisms noted 
above, some evidence indicates that RE may i) exert anti-inflammatory effects [112] 
through inhibition of interleukin-1 (IL-1) and cyclooxygenase 2 (COX2) molecules, ii) 
aid in the reversal of acquired drug resistance [119] by inhibiting P-glycoprotein levels 
(correlated with drug resistance), and iii) alter metabolic-related genes [109] such as 
glycosyltransferase (GCNT3) which forms glycosidic linkages in a variety of 
macromolecules and its potential epigenetic regulator microRNA-15b. Although many 
studies suggest that induction of apoptosis is an important mechanism of RE, there is 
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little evidence to support the antiproliferative mechanism of RE. As well, the effects of 
RE in aggressive cancers such as liver and lung cancer have yet to be explored.  
1.11 Mechanisms of anticancer effects of rosemary extract: in vivo animal 
studies 
Limited evidence exists regarding RE’s mechanism in vivo however, few studies 
list potential antioxidant effects and serum biomarkers for RE’s anticancer effects. 
Increases in glutathione (GSH), an antioxidant, and reductions in lipid peroxidase (LPx), 
an oxidizing agent resulting in free radical production and cell damage, have been 
recorded in IR-induced mouse liver [121] and DMBA-induced mouse skin cancer 
[122,123] models treated with RE. Similarly, RE decreased glutathione-S transferase 
(GST) positive foci, which are associated with oxidative damage from the reduction of 
GSH, in a rat DEN-induced liver cancer model however, results were not significant and 
should be taken with caution [120]. The presented evidence suggests a protective 
antioxidant effect by RE in vivo in animals.  
Serum samples from mice xenografted with prostate cancer cells and fed RE in 
their diet showed a decrease in prostate-specific antigen (PSA) levels (high levels would 
be suggestive of prostate cancer) and examination of tissue samples showed decreased 
androgen receptor and CHOP expression, indicative of an induction of apoptosis 
associated with endoplasmic reticular stress [118]. In colon cancer xenografted mice, a 
significant decrease in microRNA-15b (miR-15b) plasma levels after administration of 
RE suggested circulating miR-15b levels may act as a minimally invasive method to 
monitor the antitumor effects of RE in vivo [109]. Sufficient evidence exists to support 
the potential use of RE in chemotherapeutics however, before clinical trials can begin 
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more detail on RE’s mechanism and its use across all cancer cell types in vitro and in 
vivo needs to be investigated further. There still remain discrepancies in the effective 
doses of RE and whether the anticancer effects seen are attributable to individual 
polyphenols (such as CA, RA or CN) or to all the components of RE combined. 
Chapter 2: Rationale, Objectives and Hypotheses of the 
Present Study  
 
2.1 Rationale 
It is well established that cancer cells harbor the ability to grow and divide 
uncontrollably compared to non-cancerous cells. This ability comes from various 
mutations and deletions to key proteins involved in cell signaling such as the 
PI3K/Akt/mTOR, Ras/MAPK and AMPK pathways as discussed in Chapter 1. Many 
drugs and therapies have been developed which target these signaling pathways. 
Unfortunately, tumor cell populations often develop a resistance to both chemo- and 
radio-therapies. Discovery of novel compounds/chemicals is necessary to expand options 
for therapy, overcome resistance and improve patient outcome.   
Lung cancer is the leading cause of cancer mortality worldwide in both men and 
women [124]. Despite advances in treatment such as chemo-and radiation therapy, 
survival has improved little over the past few decades [125] and the 5 year survival rate 
for all stages is less than 15% [126]. Non-small cell lung cancer (NSCLC) accounts for 
almost 80% of all lung cancer cases [127] and represents the most aggressive form of the 
disease, with a 1-year survival rate of 16% [128]. This highlights the necessity to develop 
new therapeutic strategies for lung cancer patients and thus, cell lines of this histology 
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will be used in this study. Approximately 50-80% of NSCLCs are associated with EGFR 
overexpression; with 65% of them are also found to have an increased EGFR gene copy 
number [129–131]. Furthermore, high levels of EGFR expression has been associated 
with a poor prognosis in lung cancer patients [132–134], warranting exploration of 
potential chemotherapeutics targeting EGFR-associated signaling pathways such as 
PI3K/Akt, Ras/MAPK and the cell energy sensing pathway involving AMPK.   
 The Mediterranean diet has long been attributed to preventing or delaying the 
onset of cardiovascular disease, diabetes and various cancers. One component of the 
Mediterranean diet which may contribute to these effects is rosemary, a commonly used 
herb in the Mediterranean. Rosemary extract has been shown to exert anticancer 
properties including decreased cell growth and proliferation, and enhanced apoptotic 
activity in vitro and in vivo in colon [108,109], breast [112,114], prostate [118] and 
leukemic [115,116] cancers, among others. Limited data exists regarding the effects of 
rosemary extract in lung cancer and little is known about the signaling mechanisms of its 
antiproliferative properties.  
 Historically, many plants and food components have been the basis for isolation 
of compounds that are used in the treatment of various maladies. Acetylsalicylic 
acid/salicylate (Aspirin), commonly used to treat minor pain and reduce inflammation, 
was isolated from the willow tree; and morphine, used to treat pain, is an opioid isolated 
from the opium poppy. Recently the polyphenol resveratrol, found in wine has been 
shown to have potent anticancer properties. Thus, further investigation of compounds 
found in plants such as rosemary may lead to the discovery of chemicals with potent 
anticancer properties.  
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 The main polyphenolic compounds present in rosemary extract, carnosic acid and 
rosmarinic acid will also be explored to examine if the anticancer properties of rosemary 
are attributable to any of these individual compounds or if any synergistic or additive 
interactions exist between these compounds.  
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2.2 Objectives 
The objectives of the study are to: 
1) Examine the effects of rosemary extract on proliferation and clonogenic 
survival in various human lung cancer cells and normal lung fibroblasts;  
2) Examine the cell signaling pathways which may be implicated in rosemary 
extracts’ mechanism of action involving cell survival and proliferation in various 
human lung cancer cell lines; 
3) Examine the anticancer effects of the main polyphenolic compounds found in 
rosemary extract, rosmarinic acid, and carnosic acid on various human lung 
cancer cell lines and normal lung fibroblasts; 
4) Examine cell signaling pathways which may be implicated in rosmarinic acid 
and carnosic acids mechanism of action involving cell survival and proliferation 
in various human lung cancer cell lines; 
5) Determine if the main polyphenolic components found in rosemary extract, 
rosmarinic acid and carnosic acid act synergistically to exert anticancer effects in 
various human lung cancer cell lines. 
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2.3 Hypotheses 
 
In the present study it is hypothesized that: 
 
1) Rosemary extract decreases proliferative capacity and clonogenic survival in 
NSCLC cells; 
2)  The main polyphenols found in rosemary extract, rosmarinic acid and carnosic 
acid decrease proliferative capacity and clonogenic survival in NSCLC cells; 
3) Rosemary extract and its main polyphenolic components, rosmarinic acid and 
carnosic acid, alter key signaling pathways involved in cell proliferation and 
survival in NSCLC cells; 
a) Rosemary extract and its main polyphenolic components, rosmarinic 
acid and carnosic acid, inhibit the PI3K/Akt and Ras/MAPK (ERK) 
pathways; 
b) Rosemary extract and its main polyphenolic components, rosmarinic 
acid and carnosic acid, activate the energy sensing molecule AMPK; 
4) The main polyphenols found in rosemary extract, rosmarinic acid and carnosic 
acid work synergistically to exert anticancer effects. 
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Chapter 3: Methodology  
 
3.1 Cell lines 
 
Cells in culture were used to investigate the anticancer effects of rosemary extract 
and its main polyphenolic components. These cells resemble the primary tumor 
population but offer a homogenous population of cells with unlimited replicative 
capacity. The use of cultured cells to investigate the physiology and biochemistry of cells 
and intracellular signaling pathways is well-established. Immortalized or continuous cell 
lines are capable of evading cellular senescence and divide continuously. These cells can 
be used for experiments in vitro and environmental factors can be manipulated. The cell 
lines used in this study were non-small cell lung cancer (NSCLC) cells with varying 
histologies and mutations which represent the variation that is seen in cancer diagnoses in 
humans, and a normal lung fibroblasts cell line for comparison. 
MRC-5 are normal long fibroblasts which do not differentiate. This cell line was derived 
from the normal lung tissue of a 14-week-old Caucasian male fetus by J.P. Jacobs in 
1966. [135].  
A549 are epithelial NSCLC adenocarcinoma cells. This cell line was derived from lung 
carcinoma tissue of a 58-year-old Caucasian male by D.J. Giard in 1972 [136]. 
H1299 are epithelial NSCLC adenocarcinoma cells. This cell line was derived from a 
lymph node metastasis of the lung from a 43-year-old Caucasian male who had received 
previous radiation therapy [137]. 
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H460 are epithelial large cell lung carcinoma cells. This cell line was derived from the 
pleural fluid of a male with large cell cancer of the lung by A.F. Gazdar and associates in 
1982 [138].  
The histology and the known mutations of the cell lines used are summarized in Table 10.  
Table 10: Lung cancer cell line properties 
Cell 
Line 
Histology Mutations 
MRC-5 Lung fibroblast  No known mutations 
A549 NSCLC 
adenocarcinoma 
KRAS mutant; LKB1 null; express wt p53;   
M CDKN2A[p16]; M CDKN2a[p14] 
H1299 NSCLC 
adenocarcinoma 
express LKB1; p53 null; NRAS mutant 
H460 NSCLC large cell 
carcinoma 
KRAS mutant; LKB1 null; express easily 
detectable wt p53; PIK3CA mutant 
 
3.2 Materials 
 Cell culture materials including Roswell Park Memorial Institute (RPMI) 1640 
medium, Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum (FBS), 
antibiotic-antimycotic solution and trypsin were purchased from GIBCO Life 
Technologies (Burlington, ON). Cell culture materials including 75cm2 flasks, 6 well 
plates, 96 well plates, conical tubes, Eppendorf tubes, pipette tips and syringe filters were 
purchased from VWR International (Mississauga, ON).  Non-small cell lung cancer 
(NSCLC) cell lines A549, H1299, H460 and normal lung fibroblasts MRC-5 were 
purchased from American Type Culture Collection (ATCC) (Virginia, USA). Chemicals 
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including carnosic acid (>91% purity), rosmarinic acid (>98% purity), trans-resveratrol 
(>99% purity), metformin, dimethyl sulfoxide (DMSO), bovine serum albumin (BSA), 
formalin, crystal violet, methylene blue and buffer salts were purchased form Sigma 
Aldrich (Oakville, ON). Western blotting materials including glass plates, polyvinylidene 
fluoride (PVDF) membrane, running and transfer apparatus, sodium dodecyl sulfate 
(SDS), Tris-base, glycine, 2-mercaptoethanol, bromophenol blue, TEMED, Tween, 
ammonium persulfate (APS), phenylmethanesulfonyl fluoride (PMSF), acrylamide/Bis 
solution, molecular weight protein standards, protein assay dye reagent, luminol/enhancer 
and peroxide solution were purchased from Bio-Rad (Mississauga, ON). Total and 
phospho-specific antibodies including Akt, ERK (p44/42 MAPK), AMPK and beta actin, 
as well as IgG HRP-linked anti-rabbit secondary antibody were purchased from New 
England Biolabs (Mississauga, ON).  
3.3 Buffers and solutions 
The buffers and solutions required for each experiment and their compositions are 
provided below:  
Cell Lysis 
Phosphate Buffered Saline (PBS) Solution- Wash Buffer 
137mM NaCl; 2.7mM KCl; 1.5mM KH2PO4; 8.1mM Na2HPO4; 0.68mM CaCl2; 
0.49mM MgCl2; Add distilled water to achieve final volume, adjust pH to 7.4 and 
sterilize (autoclave) before use.  
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Cell Lysis Buffer 
20mM Tris-HCl solution (pH 7.5); 150mM NaCl; 1mM EDTA; 1mM EGTA; 1% Triton 
X-100; 2.5mM Na4P2O7; 1mM glycerol 2-phosphate; 1mM Na3VO4; 1µg/mL leupeptin; 
add 1mM PMSF before use and chill on ice.  
3X SDS Sample Buffer 
187.5mM Tris-HCl solution (pH 6.8); 6% w/v SDS; 30% glycerol, 0.03% bromophenol 
blue; deionized water; add 0.15% β-mercaptoethanol before use. 
Western blotting solutions 
1.5M Tris-HCl (pH 8.8) 
27.23g Tris base (18.15g/100mL); 80mL deionized water; adjust pH to 8.8 with 6N HCl 
and bring total volume to 150mL with deionized water 
0.5M Tris-HCl (pH 6.8) 
6g Tris base (6g/100mL); 60mL deionized water; adjust pH to 6.8 with 6N HCl and bring 
total volume to 100mL with deionized water.  
Resolving Gel Buffer (10%) – for 4 1.5mm gels 
12.3mL deionized water; 9.9mL 30% acrylamide/Bis solution; 7.5mL 1.5M Tris-HCl (pH 
8.8); 0.3mL 10% w/v SDS. Right before pouring gel add 150µL 10% APS (0.01g into 
100µL deionized water) made fresh daily and 30µL TEMED and swirl. 
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Stacking Gel Buffer (4%) – for 4 1.5mm gels18.3mL deionized water; 3.9mL 30% 
acrylamide/Bis solution; 7.5mL 0.5M Tris-HCl (pH 6.8); 0.3mL 10% w/v SDS. Right 
before pouring gel add 150µL 10% APS (0.01g into 100µL deionized water) made fresh 
daily and 30µL TEMED and swirl. 
10x Tris-Buffered Saline (TBS) 
24.2g Tris base; 80g NaCl; fill to total volume of 1L with deionized water; adjust pH to 
7.6 with HCl. Use as 1x TBS/T (50mL 10x TBS into 450mL deionized water; then add 
500µL Tween). 
10x Electrode Running Buffer 
15.15g Tris base; 72g glycine; 5g SDS; dissolve and bring volume to 500mL with 
deionized water. Do not adjust pH. Before use dilute to 1x (50mL 10x stock into 450mL 
deionized water). 
Transfer Buffer 
25mM Tris base (3.03g); 0.2M glycine (15.01g); 20% methanol (200mL/800mL 
deionized water); adjust final volume to 1L.  
Blocking Buffer 
15mL 10xTBS; 135mL deionized water; 7.5g nonfat dry milk (5%w/v); 0.15mL Tween; 
make fresh each time. 
Primary Antibody Dilution Buffer 
2mL 10xTBS; 18mL deionized water; 1.0g BSA; 20µL Tween (add after first 3 
ingredients are mixed); add 10µL primary antibody before use. 
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Secondary Antibody Buffer 
10mL blocking buffer; 5µL secondary antibody; make fresh each time. 
Crystal violet assay solutions 
Crystal Violet Stain 
0.5% w/v crystal violet stain in 25% v/v methanol; keep solution covered from light 
Solubilizer Solution 
0.05M NaH2PO4 (MW 119.98g/mol) in 50% v/v ethanol; keep solution covered from 
light 
 3.4 Cell culture  
A549, H1299 and H460 NSCLC cells were cultured in RPMI 1640 medium 
containing 2.05mM L-glutamine and supplemented with 1% (v/v) antibiotic-antimycotic 
(100 U/mL penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin) and 10% 
(v/v) FBS. MRC-5 normal lung fibroblasts were cultured in DMEM media containing 
high glucose and supplemented with 1% (v/v) antibiotic-antimycotic (100 U/mL 
penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin) and 10% (v/v) FBS. 
Media was changed every 48 -72 hours and cells were treated with trypsin and passaged 
once 70-80% confluency was reached. Cells were maintained in an incubator at 37º C and 
5.0% carbon dioxide (CO2) – 95% air. Concentrations and time course for each 
experiment are listed under each figure. Cell handling was performed in a Forma Class II, 
A2 Biological Safety Cabinet (BSC). 
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3.5 Rosemary extract preparation 
 A methanol extract of rosemary (RE) was prepared as previously described [139]. 
Whole dried rosemary (Rosmarinus Officinalis L.) leaves (purchased from 
Compliments/Sobey’s, Mississauga, ON, Canada- product of Turkey) were ground and 
passed through a mesh sieve and extracted following protocols established by the 
National Cancer Institute of the U.S. The ground plant (5g) was steeped overnight (16 
hours) in dichloromethane-methanol (1:1) (30mL). The filtrate was collected under slight 
vacuum followed by methanol (30mL) extraction for 30 minutes. The solvent was 
removed by rotary evaporation. Aliquots were prepared in dimethyl sulfoxide (DMSO) 
(100mg/mL) and stored at -20 degrees Celsius.  
3.6 Crystal violet assay 
 The crystal violet assay was used to assess cell proliferation (growth). The crystal 
violet stain binds DNA and thus measures the ability of cells to grow and divide. Cells 
were seeded (800-1000; counted using haemocytometer) in triplicate in 100µL 
supplemented media in 96 well plates and allowed to adhere overnight. The following 
day, treatments were added with an extra 100µL supplemented media (final volume per 
well is 200µL) and cells were maintained in the incubator for 72 hours. At the end of the 
time course media was removed, cells were fixed with 10% formalin (100µL/well), 
rinsed using PBS and stained using crystal violet dye (50µL/well). Stain was removed by 
submerging plates in tap water and plates were allowed to dry overnight. The following 
day solubilizer solution was added (100µL/well) and absorbance was read at 570nm 
using the KC4 microplate reader. 
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3.7 Clonogenic assay 
 The clonogenic assay was used to assess the colony forming abilities of the cells. 
Colony formation is characteristic of cancer cells that are highly developed and able to 
form tumors and become more aggressive. Cells were seeded (1000; counted using 
haemocytometer) in triplicate in 2mL supplemented media in 6-well plates and allowed 
to adhere overnight. The following day, media was removed, treatments were 
administered (2mL per well) and cells were maintained in the incubator for 7 days. At the 
end of the time course, media was aspirated and cells were washed twice with 1X PBS 
before being stained with 0.05% w/v methylene blue in distilled water. Cells were stained 
for 10-15 minutes and left on the counter to dry overnight before counting. Colonies 
greater than 50 cells were counted under the microscope and results are expressed as the 
surviving fraction compared to untreated control.  
3.8 Cell lysis 
 Cells were seeded in duplicate in 6 well plates and maintained in the incubator 
until 90-100% confluency. Cells were treated with the indicated concentrations of the 
various agents for 24-72 hours. Following treatment, cell lysis was performed using cell 
lysis buffer with PMSF (150µL/well) on ice and a plastic cell scraper. Lysates were 
pipetted into 1.5mL Eppendorf tubes and 50µL was removed for protein assay. Lysates 
were dyed using 3x SDS sample buffer by adding 1:3 ratio of dye to lysate. Samples were 
then boiled for 5 minutes and stored in -20ºC until use. 
3.9 Protein assay 
The protein assay was performed to ensure sufficient protein was present in the 
cell lysate samples and to determine the correct loading volume of each sample to be 
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used in Western blotting. Dilutions of BSA protein standards were prepared by loading 
10µl each 0, 0.1, 0.2, 0.4, 0.6, 0.8, 0.9 and 1.0 mg/mL BSA in distilled water (in 
triplicate) into a 96 well plate and a standard curve was formulated. Lysate samples were 
pipetted in triplicate into a 96-well plate (10µl/well) followed by addition of 200µl of 
diluted Biorad protein assay dye reagent (1:4 dye reagent to distilled water) to each well. 
Samples were incubated at room temperature for 5-10 minutes and absorbance was 
measured using KC4 microplate reader at 595nm. Briefly, the acidic dye binds to certain 
amino acids in the protein causing a spectral shift of the dye from brown to blue, where 
blue has a maximum absorbance at 595nm. The samples absorbance in comparison to the 
standards absorbance can then be used to calculate the final protein concentration in the 
samples. 
3.10 Western blotting 
 Western blotting was used to examine the inhibition/activation of specific 
signaling cascades by measuring total and phosphorylated (measure of activity) levels of 
proteins of interest such as Akt, ERK and AMPK. Lysate samples containing 20-25µg 
protein were loaded alongside the Biorad Kaleidoscope ladder and separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% polyacrylamide 
gels. Samples were then transferred onto PVDF membrane and incubated in blocking 
buffer for 1 hour at room temperature. The membrane was incubated with primary 
antibody buffer overnight at 4 ºC and the following day the membrane was incubated 
with horse radish peroxidase (HRP)-linked IgG anti-rabbit secondary antibody for 1 hour 
at room temperature before being developed (using LI-COR C-Digit software). Signals 
were detected using Biorad Clarity Western ECL Solution.  Densitometric analysis was 
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performed using Image J Software. β-actin was used as loading control and band 
densities of all samples were normalized to β-actin bands before being compared to 
control. 
3.11 Statistical analysis 
 
 The results are the mean ± standard error mean of the indicated number of 
independent experiments. Analysis of Variance (ANOVA) with Tukey post-hoc test or 
Student’s paired t-test was used. Statistical significance was assumed at P<0.05. 
Statistical tests were performed using Graphpad Prism software. 
Chapter 4: Results 
 
4.1 Biological effects of rosemary extract (RE) in NSCLC cells and non-
cancerous lung fibroblasts 
 
4.1.1 Effects of RE on cell proliferation in NSCLC cells and non-cancerous lung 
fibroblasts 
 
 The antiproliferative effects of RE were evaluated in A549, H460 and H1299 
NSCLC cells and in MRC5 non-cancerous lung fibroblasts. RE has previously been 
shown to inhibit proliferation in other cancer cell lines [107,108,116]. All cell lines were 
treated with 2.5, 5, 10, 25, 50, 100, 150 and 200 µg/mL RE for 72 hours (Figure 8). 
Absorbance values (of crystal violet dye) were measured for each treatment group and 
compared to control, untreated cells (incubated in 10% FBS containing media alone). An 
incubation time of 72 hours was chosen based on preliminary data performed in our lab 
which showed 72 hours resulted in more defined antiproliferative effects compared to 48 
hours. In A549 cells, RE showed significant inhibition of proliferation at the lowest dose 
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of 2.5µg/mL (84±7.1%, p<0.05). The lowest concentration of RE to result in significant 
inhibition of proliferation in H460 and H1299 cells was 25µg/mL (50.4±4.8%, p<0.001) 
and 2.5µg/mL (88.4±4.8%, p<0.05) respectively. The maximum inhibitory concentration 
of RE was 50 (21.9±2.6%, p<0.001), 50 (30.7±3.0%, p<0.001) and 25 µg/mL (23.3±1.3, 
p<0.001) in A549, H460 and H1299 cells respectively. In MRC5 cells, significant 
inhibition of proliferation was seen at doses above 25µg/mL (71.0±1.1, p<0.05). 
Inhibition of this non-cancerous lung cell line, although significant, was much less 
compared to the cancerous NSCLC cell lines tested. The IC50 of RE was 15.9µg/mL in 
A549, 57.2µg/mL in H460, 19µg/mL in H1299 and 103.5µg/mL in MRC5. Microscopic 
examination of NSCLC cell morphology revealed some cell rounding at doses above 
100µg/mL however, no cells had lifted off the plate. No changes to cell morphology were 
seen at doses of or below 100µg/mL. No changes in cell morphology were seen at any 
dose in the MRC5 cell line. The RE used for all studies was dissolved in 
dimethylsulfoxide (DMSO). Cells were never exposed to more than 0.1% DMSO in any 
treatment. As well, DMSO at 0.1% was tested in parallel with RE experiments 
(Appendix-Figure s1) and no inhibition of proliferation was seen, confirming that the 
inhibitory effects seen were due to RE alone. These results indicate RE inhibits cell 
proliferation in NSCLC cells with varying histologies and mutations. 
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Figure 8: Effect of RE on cell proliferation in NSCLC cells. A) A549 B) H460 C) 
H1299 and D) MRC5 cells were seeded in triplicate and incubated with the indicated 
concentrations of RE for 72h followed by fixing and staining with 0.5% crystal violet. 
Stain was solubilized and absorbance was read at 570nm. Results are expressed as the 
mean % cell proliferation ± SEM compared to untreated control of 3-4 individual 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
 The inhibitory effect of resveratrol, a well-studied plant compound which has 
been shown to have potent anticancer effects [140,141] on cell proliferation were also 
examined. At the maximum inhibitory concentration of each cell line (mentioned 
previously), RE showed a similar effect compared to 100µM resveratrol (22.3±2.5% in 
A549, p<0.001; 42.6±2.3% in H460, p<0.001; 17.8±2.3% in H1299, p<0.001) (Figure 9). 
Results suggest RE has potential as an effective anticancer agent.  
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Figure 9: Effect of RE on cell proliferation in NSCLC cells is comparable to RSV. 
A) A549 B) H460 and C) H1299 cells were seeded in triplicate and incubated with the 
indicated concentrations of RE or RSV for 72h followed by fixing and staining with 0.5% 
crystal violet. Stain was solubilized and absorbance was read at 570nm. Results are 
expressed as the mean % cell proliferation ± SEM compared to untreated control of 3-4 
individual experiments. ***p<0.001.  
  
4.1.2 Effects of RE on cell survival in NSCLC cells  
 
 The ability of cancer cells to survive and form colonies was assessed using the 
clonogenic survival assay with varying concentrations of RE (2.5, 5 and 10µg/mL). 
Following a 7 day incubation with RE, cells were fixed and stained, and colonies with 
greater than 50 cells were counted and compared to control, untreated cells (incubated in 
10% FBS containing media alone). These large colonies are an indication of the cells 
potential to survive and establish tumor formation in vivo. Survival of MRC5 was not 
tested because this cell line is non-cancerous and does not form colonies. Significant 
inhibition of survival was seen with 2.5µg/mL RE in all cell lines (39.3±3.1% in A549, 
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p<0.001; 65.1±7.9% in H460, p<0.01; 42.3±1.9% in H1299, p<0.001) (Figure 10). At 
10µg/mL RE caused near complete inhibition of survival in A549 (1.2±3.1%, p<0.001) 
and H1299 (0.8±0.6%, p<0.001) cells. Inhibition of survival in H460 at 10µg/mL was 
25.8±5.9% (p<0.001). Taken together, these results suggest that RE has potent anticancer 
effects and inhibits cell proliferation and survival in vitro in various NSCLC cell lines.  
 
Figure 10: Effect of RE on clonogenic survival in NSCLC cells. A) A549 B) H460 and 
C) H1299 cells were seeded in triplicate at a low density and incubated with the indicated 
concentrations of RE for 7 days followed by fixing and staining with 0.05% methylene 
blue. Colonies of more than 50 cells were counted. Results are expressed as the mean 
surviving fraction ± SEM compared to untreated control of 3-4 individual experiments. 
**p<0.01, ***p<0.001.  
 
4.1.3 Effect of RE on Akt signaling in various NSCLC cell lines 
 
 Next, we examined the potential underlying mechanisms involved in RE’s ability 
to inhibit cell proliferation and survival in NSCLC cells. The signaling molecule Akt is 
largely involved in controlling cell proliferation in cancer cells and signaling through this 
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pathway is often enhanced in cancer, leading to a resistance to radiation and 
chemotherapy [36].  Thus, Akt is an important molecule to examine when testing 
potential anticancer agents. Phosphorylation of Akt on the serine 473 residue has been 
established as an indicator of Akt activity [20] and therefore a phospho-specific antibody 
against this residue (Ser 473) was used. All NSCLC cell lines were treated without 
(control) or with RE at 25 and 50µg/mL for 48h and a dose-dependent effect was seen in 
each cell line when compared to control (Figure 11). RE inhibited Akt phosphorylation in 
A549 cells at both concentrations (25µg/mL: 57.0±5.04%, p<0.001; 50µg/mL: 
36.1±4.9%, p<0.001) however, the same effect was not seen in H460 or H1299 cells 
which showed enhanced Akt phosphorylation. Total levels of the Akt protein were 
significantly inhibited dose-dependently by RE in all cell lines: A549 
(25µg/mL:49.8±5.3%; 50µg/mL: 32.4±0.7%) H460 (25µg/mL:74.8±5.2%; 
50µg/mL:59.9±6.0%) H1299 (25µg/mL:57.4±2.9%; 50µg/mL:39.8±4.7%). These results 
suggest that RE is able to alter Akt signaling (and total protein levels) in NSCLC cells. 
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Figure 11: Effect of RE on Akt signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RE for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against Akt. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
4.1.4 Effect of RE on ERK signaling in various NSCLC cell lines 
  
 The signaling molecule ERK is also largely implicated in cancer and leads to cell 
growth and proliferation therefore, we wished to examine RE’s effects on this protein and 
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its activation. Phosphorylation of ERK on the threonine 202 and tyrosine 204 
(Thr202/Tyr204) residues in the activation loop lead to its activation and thus a phospho-
specific antibody against these residues was used. All NSCLC cell lines were treated 
without (control) or with RE at 25 and 50µg/mL for 48h and a dose-dependent effect was 
seen in each cell line when compared to control (Figure 12). Phosphorylation of ERK 
was enhanced in all cell lines: A549 (25µg/mL:148.9±12.8%; 50µg/mL:175.8±10.7%), 
H460 (25µg/mL:136.0±9.0%; 50µg/mL:158.7±14.7%) with H1299 
(25µg/mL:172.9±2.7%; 50µg/mL:211.7±11.8%) being the most sensitive. Similar to the 
effect seen on Akt, RE inhibited total levels of ERK in all cell lines: A549 
(25µg/mL:77.7±3.9%; 50µg/mL:63.5±7.6%), H460 (25µg/mL:82.0±2.8%; 
50µg/mL:61.0±1.0%), H1299 (25µg/mL:54.4±4.2%; 50µg/mL:37.8±3.2%). These results 
suggest RE decreases total protein levels of ERK and enhances its activation in NSCLC. 
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Figure 12: Effect of RE on ERK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RE for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against ERK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
4.1.5 Effect of RE on AMPK signaling in various NSCLC cell lines 
 
 The energy sensing molecule AMPK which helps maintain energy homeostasis 
within the cell is emerging as an important protein which becomes deregulated in cancer 
and can lead to cell growth and proliferation. Therefore, we wished to examine RE’s 
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effects on its activation.  Phosphorylation of AMPK on the threonine 172 residue of its 
catalytic alpha subunit by the tumor suppressor LKB1 is required for its activation [59] 
and thus a phospho-specific antibody against this residue was used. All NSCLC cell lines 
were treated without (control) or with RE at 25 and 50µg/mL for 48h and a dose-
dependent effect was seen in each cell line when compared to control (Figure 13). 
Phosphorylation of AMPK was enhanced only in H1299 cells (25µg/mL:173.3±13.7%; 
50µg/mL:234.6±10.0%) while a small but significant inhibition was seen in A549 
(25µg/mL:88.0±4.3%; 50µg/mL:78.7±2.5%) and H460 (25µg/mL:92.6±1.7%; 
50µg/mL:80.3±2.1%) cells, when compared to control. Total levels of AMPK were 
decreased dose-dependently by RE in all cell lines: A549 (25µg/mL:84.6±1.4%; 
50µg/mL:73.8±1.4%), H460 (25µg/mL:86.8±3.0%; 50µg/mL:72.1±4.3%), H1299 
(25µg/mL:71.7±7.9%; 50µg/mL:62.4±6.9%). These results suggest RE decreases total 
protein levels of AMPK in NSCLC and alters AMPK activation.  
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Figure 13: Effect of RE on AMPK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RE for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against AMPK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
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Table 11: Summary of the effects of RE on cell signaling in NSCLC cells by 
mutation status  
Mutation Status Cell Line Total Protein Levels Phospho Protein Levels 
KRAS mutant A549 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↓ 
ERK ↑ 
AMPK ↓ 
H460 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↑ 
ERK ↑ 
AMPK ↓ 
H1299 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↑ 
ERK ↑ 
AMPK ↑ 
PIK3CA mutant H460 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↑ 
ERK ↑ 
AMPK ↓ 
LKB1 null A549 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↓ 
ERK ↑ 
AMPK ↓ 
H460 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↑ 
ERK ↑ 
AMPK ↓ 
p53 null H1299 Akt ↓ 
ERK ↓ 
AMPK ↓ 
Akt ↑ 
ERK ↑ 
AMPK ↑ 
 
 
4.2 Biological effects of one of RE’s major polyphenolic compounds, carnosic 
acid (CA) in NSCLC cells and non-cancerous lung fibroblasts 
 
4.2.1 Effects of CA on cell proliferation in NSCLC cells and non-cancerous lung 
fibroblasts 
 
 RE showed potent anticancer effects and thus, we examined if these effects may 
be attributable to CA, one of RE’s main polyphenolic compounds. Carnosic acid was 
tested at concentrations of 0.1, 0.3, 1, 5, 25, 50, 100 and 200µM in A549, H460 and 
H1299 NSCLC cells and in MRC5 non-cancerous lung fibroblasts for 72 hours (Figure 
14). The concentration of 0.3µM was included to represent the concentration of CA 
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found in 5µg/mL RE, which showed significant inhibition of proliferation in A549 and 
H1299 cells (Shown previously in Figure 8). All other concentrations were chosen to 
create a dose-response curve and include those previously shown to have antiproliferative 
effects in the literature in other cell lines [109,142,143]. Absorbance values (of crystal 
violet dye) were measured for each treatment group and compared to control, untreated 
cells (incubated in 10% FBS containing media alone). An incubation time of 72 hours 
was chosen so results were comparable to those from RE (Section 4.1). The lowest dose 
of CA to cause significant inhibition of proliferation was 100µM (50.5±7.4%, p<0.001) 
in A549, 25µM (77.9±4.2%, p<0.05) in H460 and 50µM (56.6±14%, p<0.05) in H1299 
cells. No inhibition of proliferation was seen at 0.3µM in any cell line (100.2±4.0% in 
A549; 95.3±3.2% in H460; 107.7±4.4% in H1299). In MRC5 non-cancerous cells, 
significant inhibition of proliferation was seen at 50µM (72.7±6.0%, p<0.05). The CA 
used for all studies was dissolved in dimethylsulfoxide (DMSO). Cells were never 
exposed to more than 0.1% DMSO in any treatment. As well, DMSO at 0.1% was tested 
in parallel with CA experiments (Appendix-Figure s1) and no inhibition of proliferation 
was seen, confirming that the inhibitory effects seen were due to CA alone. These results 
suggest that CA alone, at higher doses, may have anticancer effects in NSCLC however, 
the antiproliferative effects of RE are not attributable to this compound alone.  
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Figure 14: Effect of CA on cell proliferation in NSCLC cells. A) A549 B) H460 C) 
H1299 and D) MRC5 cells were seeded in triplicate and incubated with the indicated 
concentrations of CA for 72h followed by fixing and staining with 0.5% crystal violet. 
Stain was solubilized and absorbance was read at 570nm. Results are expressed as the 
mean % cell proliferation ± SEM compared to untreated control of 3-4 individual 
experiments. *p<0.05, ***p<0.001.  
 
4.2.2 Effects of CA on cell survival in NSCLC cells 
 
 Next, we examined the effect of CA alone on clonogenic survival of A549, H460 
and H1299 NSCLC cells. Significant inhibition of survival was seen with 25µM in all 
cell lines (48.2±10.9% in A549, p<0.01; 36.7±9.7% in H460, p<0.001; 7.1±1.0% in 
H1299, p<0.001). The H1299 cell line appear to be most sensitive to the CA treatment 
(Figure 15).  
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Figure 15: Effect of CA on clonogenic survival in NSCLC cells. A) A549 B) H460 and 
C) H1299 cells were seeded in triplicate at a low density and incubated with the indicated 
concentrations of CA for 7 days followed by fixing and staining with 0.05% methylene 
blue. Colonies of more than 50 cells were counted. Results are expressed as the mean 
surviving fraction ± SEM compared to untreated control of 3-4 individual experiments. 
**p<0.01, ***p<0.001.  
 
4.2.3 Effect of CA on Akt signaling in various NSCLC cell lines 
 
As mentioned in section 4.1.3, Akt is an important molecule involved in cancer 
cell growth and survival. Since RE had a significant effect on altering Akt levels we 
wanted to examine if this was attributable, at least in part, to CA one of its main 
polyphenols. Phosphorylation of Akt was inhibited by 50µM CA in A549 (66.9±3.7%) 
and H1299 (82.0±3.5%) and enhanced in H460 (112.7±3.1%) cells. However, at 3µM the 
concentration of CA found in 50µg/mL of RE which caused maximum inhibition of 
proliferation and survival (section 4.1), no significant effects were seen. Total Akt levels 
were not altered by CA in any cell line.  
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Figure 16: Effect of CA on Akt signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of CA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against Akt. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
4.2.4 Effect of CA on ERK signaling in various NSCLC cell lines 
 
 Activation of ERK was shown to be enhanced in all NSCLC cell lines by RE 
(section 4.1) hence, we investigated if CA, one of rosemary’s main polyphenols was 
responsible for this effect. At 50µM CA enhanced phosphorylation of ERK in all cell 
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lines: A549 (131.6±6.3%), H460 (122.9±7.8%), H1299 (156.8±13.6%). No significant 
effect was seen by 3µM CA and total levels of ERK were not affected in any cell line 
(Figure 17).  
 
Figure 17: Effect of CA on ERK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of CA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against ERK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
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4.2.5 Effect of CA on AMPK signaling in various NSCLC cell lines 
 
Phosphorylation of AMPK was enhanced by RE in H1299 cells (section 4.1). We 
investigated if CA, one of rosemary’s main polyphenols was responsible, at least in part, 
for this effect. At 50µM CA enhanced phosphorylation of AMPK in H1299 
(169.5±10.4%) cells. No significant effect was seen in A549 cells and a slight inhibition 
of phosphorylation was seen in H460 (91.8±1.9%) cells compared to control. No 
significant effect was seen by 3µM CA and total levels of AMPK were not affected in 
any cell line (Figure 18). 
 
 
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
78 
 
 
Figure 18: Effect of CA on AMPK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of CA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against AMPK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
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Table 12: Summary of the effects of CA on cell signaling in NSCLC by cell line and 
mutation status 
Cell Line Mutation Status Total Protein Level Phospho Protein Level 
A549 KRAS mutant 
LKB1 null 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↓ 
ERK ↑ 
AMPK ↔ 
H460 KRAS mutant 
LKB1 null 
PIK3CA mutant 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↑ 
ERK ↑ 
AMPK ↓ 
H1299 KRAS mutant 
p53 null 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↓  
ERK ↑ 
AMPK ↑ 
 
4.3 Biological effects of one of RE’s major polyphenolic compounds, 
rosmarinic acid (RA) in NSCLC cells and non-cancerous lung fibroblasts 
 
4.3.1 Effects of RA on cell proliferation in NSCLC cells and non-cancerous lung 
fibroblasts 
 
 The anticancer effects of RE were found to not be attributable to CA alone 
however significant anticancer effects were seen by CA at higher concentrations. We 
next examined the antiproliferative effects of RA, another polyphenolic compound found 
in RE to determine if it contributed to RE’s anticancer effects. Rosmarinic acid was 
tested at concentrations of 1, 1.86, 10, 25, 50, 100, 200 and 300µM in A549, H460 and 
H1299 NSCLC cells and in MRC5 non-cancerous lung fibroblasts for 72 hours (Figure 
19). The concentration of 1.86µM was included to represent the concentration of RA 
found in 5µg/mL RE, which showed significant inhibition of proliferation in A549 and 
H1299 cells (Shown previously in Figure 8). All other concentrations were chosen to 
create a dose-response curve and include those previously shown to have antiproliferative 
effects or inhibit viability in the literature in other cell lines [113,144–146]. Absorbance 
values (of crystal violet dye) were measured for each treatment group and compared to 
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control, untreated cells (incubated in 10% FBS containing media alone). An incubation 
time of 72 hours was chosen so results were comparable to those from RE (Section 4.1). 
The lowest dose of RA to cause significant inhibition of proliferation was 100µM 
(51.1±8.8%, p<0.001) in A549, 25µM (87.3±3.3%, p<0.05) in H460 and 100µM 
(23.5±10.8%, p<0.001) in H1299 cells. No inhibition of proliferation was seen at 1.86µM 
in any cell line (104.7±3.9% in A549; 98.9±4.8% in H460; 99.5±10.3% in H1299). In 
MRC5 non-cancerous cells, significant inhibition of proliferation was seen at 50µM 
(70.7±5.0%, p<0.05). These results suggest that RA alone, at higher doses, may have 
anticancer effects in NSCLC however, the antiproliferative effects of RE are not 
attributable to this compound alone. 
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Figure 19: Effect of RA on cell proliferation in NSCLC cells. A) A549 B) H460 C) 
H1299 and D) MRC5 cells were seeded in triplicate and incubated with the indicated 
concentrations of RA for 72h followed by fixing and staining with 0.5% crystal violet. 
Stain was solubilized and absorbance was read at 570nm. Results are expressed as the 
mean % cell proliferation ± SEM compared to untreated control of 3-4 individual 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
4.3.2 Effects of RA on cell survival in NSCLC cells 
 
Next, we examined the effect of RA alone on clonogenic survival of A549, H460 
and H1299 NSCLC cells. Significant inhibition of survival was seen with 50µM in A549 
(62.5±4.1%, p<0.001) and H1299 (22.4±0.8%, p<0.001) cells. Significant inhibition was 
only seen in H460 cells at a concentration of 100µM (34.9±17.8%, p<0.05). Similar to 
the clonogenic survival using CA alone, the H1299 cell line appears to be the most 
sensitive to RA treatments (Figure 20).  
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Figure 20: Effect of RA on clonogenic survival in NSCLC cells. A) A549 B) H460 and 
C) H1299 cells were seeded in triplicate at a low density and incubated with the indicated 
concentrations of RA for 7 days followed by fixing and staining with 0.05% methylene 
blue. Colonies of more than 50 cells were counted. Results are expressed as the mean 
surviving fraction ± SEM compared to untreated control of 3-4 individual experiments. 
*p<0.05, ***p<0.001.  
 
4.3.3 Effect of RA on Akt signaling in various NSCLC cell lines 
 
As mentioned in section 4.1.3, Akt is an important molecule involved in cancer 
cell growth and survival. Since RE had a significant effect on altering Akt levels we 
wanted to examine if this was attributable, at least in part, to RA one of its main 
polyphenols. Phosphorylation of Akt was inhibited by 50µM RA in A549 (88.4±0.9%) 
and H1299 (74.4±5.2%) and increased in H460 (111.3±2.3%) cells however at 18µM, the 
concentration of RA found in 50µg/mL of the RE which caused maximum inhibition of 
proliferation and survival (section 4.1), no significant effects were seen. Total Akt levels 
were not altered by RA in any cell line (Figure 21).  
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Figure 21: Effect of RA on Akt signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against Akt. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
 
4.3.4 Effect of RA on ERK signaling in various NSCLC cell lines 
 
Activation of ERK was shown to be enhanced in all NSCLC cell lines by RE 
(section 4.1) hence, we investigated if RA, one of rosemary’s main polyphenols was 
responsible for this effect. At 50µM RA enhanced phosphorylation of ERK in all cell 
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lines: A549 (133.4±6.2%), H460 (138.6±6.5%), H1299 (170.6±11.9%). No significant 
effect was seen by 18µM RA and total levels of ERK were not affected in any cell line 
(Figure 22). 
 
Figure 22: Effect of RA on ERK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against ERK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001. 
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4.3.5 Effect of RA on AMPK signaling in various NSCLC cell lines 
 
Phosphorylation of AMPK was enhanced by RE in H1299 cells (section 4.1). We 
investigated if RA, one of rosemary’s main polyphenols was responsible, at least in part, 
for this effect. At 50µM RA enhanced phosphorylation of AMPK in H1299 
(138.4±5.8%) cells. No significant effect was seen in A549 or H460 cells compared to 
control. No significant effect was seen by 18µM RA and total levels of AMPK were not 
affected in any cell line (Figure 23). 
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Figure 23: Effect of RA on AMPK signaling in NSCLC cells. Whole cell lysates were 
prepared from A) A549 B) H460 and C) H1299 cells treated with the indicated 
concentrations of RA for 48h in 10% FBS containing medium. Cell lysates (20µg) were 
resolved by SDS-PAGE and immunoblotted with total- or phospho- specific antibodies 
against AMPK. A representative immunoblot is shown. The densitometry of the bands 
expressed in arbitrary units was measured using Image J software. Protein levels are 
expressed as a percentage of the control. Results represent mean ± SEM of 3 independent 
experiments. *p<0.05, **p<0.01, ***p<0.001.  
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Table 13: Summary of the effects of RA on cell signaling in NSCLC by cell line and 
mutation status 
Cell Line Mutation Status Total Protein Level Phospho Protein Level 
A549 KRAS mutant 
LKB1 null 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↓ 
ERK ↑ 
AMPK ↔ 
H460 KRAS mutant 
LKB1 null 
PIK3CA mutant 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↑ 
ERK ↑ 
AMPK ↔ 
H1299 KRAS mutant 
p53 null 
Akt ↔ 
ERK ↔ 
AMPK ↔ 
Akt ↓  
ERK ↑ 
AMPK ↑ 
 
 
4.4 Biological effects of CA and RA in combination in A549 NSCLC cells  
 
 The polyphenols CA and RA were found to have potent antiproliferative effects 
on their own in limited in vitro studies [113,144,147] and in the current study, so we 
wished to explore if the concentration of CA and RA that is present in our RE worked 
synergistically to induce the antiproliferative effects of RE. We used concentrations of 
CA and RA to match what is found in 5 (0.32µM CA; 1.86µM RA), 10 (0.64µM CA; 
3.72µM RA) and 200 (12.75µM CA; 74.32µM RA) µg/mL of our RE. CA alone showed 
no inhibition at low concentrations (0.32µM:100.5±1.8%; 0.64µM: 97.3±2.0%), as seen 
previously (Fig 14A) and a slight inhibition at 12.75µM (93.7±1.0%). RA alone also 
showed no inhibition at low concentrations (1.86µM:98.4±2.4%; 3.72µM: 97.9±0.8%), 
as seen previously (Fig 19A) but an inhibition was seen at 74.32µM (72.2±3.2%). In 
combination, a minimal effect was seen at lower doses (0.32µM CA+1.86µM RA: 
94.6±1.6%; 0.64µM CA+ 3.72µM RA: 96.0±0.5%) while a clear effect was seen at the 
higher concentration (12.75µM CA+ 74.32µM RA: 62.9±4.6%) resulting in a 
combination index (CI) of 0.43 indicating synergism.  
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Figure 24: Effect of CA and RA in combination on proliferation in A549 NSCLC 
cells. Cells were seeded in triplicate and incubated for 72h with concentrations of CA and 
RA alone and in combination, to match what is found in our RE at 5, 10 and 200µg/mL. 
Cells were fixed and stained with 0.5% crystal violet. Stain was solubilized and 
absorbance was read at 570nm. Results are expressed as the mean % cell proliferation ± 
SEM compared to untreated control of 3-4 individual experiments. CI value=0.432 
indicating a synergistic interaction.  
 
 
Chapter 5: Discussion 
 
 Lung cancer is responsible for the most cancer related deaths [124] and 
importantly, NSCLC accounts for up to 80% of all lung cancer cases [127] and represents 
the most aggressive form of the disease. Unfortunately fewer than 15% of individuals 
with NSCLC reach a 5-year survival despite use of aggressive chemo- and radiation 
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therapy [126]. Patients with NSCLC often develop resistance to these cytotoxic therapies 
[37], highlighting the need for novel anticancer strategies.  
 Cancer cells are characterized by their ability to evade homeostasis and grow 
(proliferate) uncontrollably while avoiding programmed cell death (apoptosis) [1]. They 
often acquire these characteristics through mutations to key signaling molecules which 
regulate pathways involved in cell proliferation and survival. Alternatively, there are 
increased levels of growth factors produced which, through autocrine or paracrine 
mechanisms, bind to cell surface receptors and activate these cascades. Deregulation of 
these pathways results in the aggressive growth and potential spread (metastases) of 
cancer cells [2,3]. Thus, it is important to target these pathways in the development of 
new chemotherapeutics.  
 The PI3K-Akt pathway is commonly mutated in cancer leading to enhanced cell 
proliferation through downstream mTOR-p70S6K activation [41,42] and inhibition of 
apoptosis (through p53 inhibition) [71]. The presence of a mutated Akt pathway often 
leads to resistance to chemo- and radiation therapy [36]. Similarly, KRAS mutations are 
common in aggressive cancers and can lead to enhanced signaling through the Akt or 
ERK signaling cascades. ERK, is also largely implicated in cancer cells’ enhanced 
proliferation and ability to evade apoptosis [148]. Therefore, targeting these molecules is 
of importance when considering the potential of new anticancer agents. Activity of the 
energy sensor AMPK is often decreased in cancer cells, due to loss of expression of 
upstream tumor suppressor LKB1 [149]. Enhancing AMPK activity in cancer cells leads 
to inhibition of mTOR-p70S6K and thus decreased cell growth, making this protein a 
novel target for anticancer therapies. Indeed activation of AMPK, using therapeutic drugs 
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such as metformin, has been shown to overcome drug resistance in breast cancer cells 
[65] and enhance radio-sensitivity of lung cancer cells [66].  
 Many pharmaceutical and chemotherapeutic agents have been discovered by 
screening natural products from plants. Plants rich in polyphenols have received much 
attention for their anticancer properties, among other health benefits. The herb rosemary 
has a high polyphenolic content and has recently emerged as having many health 
benefits, including potential as an anticancer agent [109,118]. Although there is evidence 
to support the potential of rosemary as an anticancer agent, limited data exists regarding 
the effects of rosemary extract in lung cancer and little is known about the signaling 
mechanisms of its antiproliferative and antiapoptotic properties.   
 In the present study we used 3 NSCLC cell lines to represent a variety of 
histologies and mutations which may be found clinically. A normal lung fibroblast cell 
line MRC5 was used for comparison. Our findings are the first to show the potent 
antiproliferative properties of RE and its main polyphenolic components CA and RA in 
NSCLC cells. Additionally, we show the effects of RE, CA and RA on Akt, ERK and 
AMPK signaling pathways, involved in cell proliferation and survival.  
 
5.1 RE inhibits lung cancer cell proliferation and survival 
 
 This study is the first to show inhibition of cell proliferation in NSCLC cells by 
RE. The A549 and H1299 cells appeared to be more sensitive to RE treatment with IC50 
values of 15.9 and 19µg/mL respectively, compared to H460 cells which had an IC50 of 
57.2µg/mL. Differences in sensitivity of the cell lines to RE is likely a result of the 
different mutations present, to be discussed in section 5.2. These results are in agreement 
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with several previous studies which examined the antiproliferative effects of RE using 
similar doses in colon [107,108], pancreas [110], leukemia [115–117] and prostate [118] 
cancer cell lines. Interestingly, at its maximum inhibitory dose in each cell line RE’s 
effects were comparable to that of 100µM resveratrol (Figure 9), an extensively studied 
polyphenol found to have significant anticancer effects [140,141]. These results 
demonstrate an antiproliferative effect of RE and support its use as an anticancer agent.  
 MRC5 lung fibroblasts were used to determine the effects of RE on a non-
cancerous cell line. A dose-dependent inhibition of cell growth was seen in MRC5 cells 
but to a lesser extent (IC50 of 103.5µg/mL) than what was seen in the NSCLC cell lines 
(IC50 ranging from 15-57µg/mL). MRC5 is an embryonic fibroblast cell line [135] and 
embryonic cell lines have been reported to display properties similar to cancer cells 
[150]. MRC-5, like cancer cells, rely heavily on glycolysis and exhibit a rather high 
proliferation rate compared to mature non-cancer cell lines [150]. In a study examining 
inhibition of cell growth by AICAR, which acts to mimic a low intracellular energy state 
and inhibit proliferation of cancer cells, MRC5 cells showed a dose-dependent growth 
inhibition by AICAR comparable to that seen in the various cancer cell lines used.  
AICAR was also able to induce Akt phosphorylation and increase hypoxia inducible 
factor (Hif1α - controls cell response to hypoxia and cell survival) content in MRC5 cells 
which are characteristic factors of cancer cells [150] however, the same effect was not 
seen in a mature non-cancerous fibroblast-like lung cell line, HLF. Thus, MRC5 cells are 
not the best model of a non-cancerous cell line in the present study and a more mature 
lung cell line should be used in future studies to determine if RE has growth inhibitory or 
apoptotic effects on epithelial cells compared to their cancerous counterparts. The higher  
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IC50 seen in MRC 5 cells compared to cancer cells together with the fact that MRC5 are 
cells of embryonic origin suggests that RE would have negligible growth inhibitory 
effects on  healthy epithelial cells which would support a role for RE to preferentially 
target cancer cells in vivo without affecting their surrounding normal cells. This 
suggestion is supported by one study showing RE enhanced levels of the endoplasmic 
stress related protein kinase RNA-like endoplasmic reticulum kinase (PERK) in prostate 
cancer cells however, RE decreased PERK levels in a normal prostate epithelium cell line 
suggesting RE selectively induces endoplasmic reticular stress in prostate cancer cells but 
spares normal prostate cells [118]. 
 After confirming that RE had antiproliferative effects in NSCLC we wanted to 
explore further the anticancer properties of RE. Another characteristic of cancer cells is 
their augmented ability to survive and form tumors, even in the harsh environments 
generated by chemo- and radiation therapy. Our findings showed that in all 3 NSCLC cell 
lines, clonogenic cell survival was inhibited dose-dependently by RE (Figure 10). 
Significant inhibition of survival was seen at 2.5µg/mL in all cell lines, although again 
the H460 cell line appeared to be the least sensitive compared to A549 and H1299 cells. 
Similarly, RE was shown to inhibit colony formation of colon cancer cells [106] and 
inhibit viability, which is an indicator of survivability, in  pancreas [109], breast 
[113,114], leukemia [113,116], prostate [113], liver [113] and small cell lung [113] 
cancer cells at doses comparable to those used here. Importantly, the study by Yesil-
Celiktas, et al (2010) is the only other study to examine lung cancer however, they used a 
small cell lung cancer cell line and the only property they explored was cell viability 
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[113]. They found RE to have an IC50 of 24.08 µg/mL in this cell line, which is 
comparable to the results, using NSCLC cells, of the present study. 
5.2 Exploring signaling molecules involved in RE’s anticancer mechanisms  
 
 Given the ability of RE to inhibit NSCLC cell proliferation and survival in this 
study (Section 5.1) and the in vivo evidence supporting RE’s ability to decrease tumor 
size and incidence in animal models of colon [109], prostate [118], leukemia [115] and 
skin [123] cancer, we next wanted to examine potential signaling cascades that were 
involved in RE’s antiproliferative mechanism. Three different NSCLC cell lines were 
used to represent varying mutations and histologies of the disease and interestingly RE 
activated/inhibited the Akt, ERK and AMPK molecules differently in each cell line 
depending on their mutations (Table 11).  
 It was hypothesized that Akt phosphorylation would be down-regulated and 
AMPK phosphorylation would be enhanced by RE in NSCLC given their important role 
in cell survival however surprisingly, Akt phosphorylation was only down-regulated in 
A549 cells (Figure 11A) and AMPK phosphorylation was only enhanced in H1299 cells 
(Figure 13C). All cell lines harbor a mutation to the Ras GTPase protein (KRAS in A549 
and H460 or NRAS in H1299) which leads to constitutive activation of Ras-PI3K-Akt 
signaling and thus, increased Akt phosphorylation. In addition to a KRAS mutation, H460 
cells have a mutant PIK3CA gene which leads in increased PI3K-Akt signaling and thus, 
increased Akt phosphorylation. Of note, both A549 and H460 cells lack expression of the 
tumor suppressor LKB1 which is an upstream regulator of AMPK [151]. A significant 
increase in AMPK activation in H1299 (LKB1 expressing) cells was seen. The fact that 
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no effect on phosphorylation of AMPK was seen in LKB1 null cells suggests that RE 
may increase AMPK phosphorylation via LKB1. No previous reports have examined 
RE’s effect on AMPK or associated proteins in this pathway in cancer and this represents 
a novel finding of this study. Interestingly, RE has been shown to enhance AMPK 
activity in L6 muscle cells resulting in increased glucose uptake, and the same study also 
showed RE to have no effect on Akt activation in these cells [139]. Akt has been shown 
to be a negative regulator of AMPK, leading to a decreased AMP/ATP ratio within the 
cell and thus inhibition of AMPK activation. Therefore, cells with enhanced Akt activity 
likely also show decreased AMPK activity [152]. This may explain why H460 cells, 
which show very high Akt phosphorylation after RE treatment, have decreased AMPK 
phosphorylation. Previous reports have found that in cancer cells, including NSCLC, 
treated with 2-deoxyglucose (2-DG), an inhibitor of glycolysis/glucose metabolism and 
potential chemotherapeutic which is known to lead to increased AMPK phosphorylation, 
increased apoptosis and inhibition of cell growth, Akt phosphorylation was in fact 
increased [153,154]. It was established that this mechanism was independent of 
LKB1/AMPK activation but was dependent on PI3K activity. Akt activation is often 
associated with cell survival and resistance to cancer therapy and in this context RE-
induced Akt activation would have adverse effects in RE-based therapy.  When Akt 
activity was inhibited, 2-DG-mediated growth inhibition was enhanced suggesting that 2-
DG would work better as an anticancer agent in combination with PI3K/Akt inhibitory 
agents such as LY294002 [153]. The same may be true for RE, which holds potential as a 
natural anticancer compound which may be used in combination with chemotherapy, IR 
or other anticancer agents.  
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 A recent study discovered that the increased Akt activation seen by 2-DG lead to, 
and was required for activation of sestrin-2, a member of a family of sestrin molecules 
which regulate oxidative and genotoxic stress [149]. Sestrin-2 is suggested to directly 
activate AMPK (forming a complex with Sestrin-2/AMPKα/TSC1/TSC2) leading to 
inhibition of mTOR and thus protein synthesis and cell growth ,in human embryonic 
kidney (HEK) and some cancer cells [156]. Sestrin 1 and 2 are target genes of p53 and 
are a critical link allowing p53 to lead to inhibition of mTOR and thus cell growth [156]. 
Increase of sestrin-2 is independent of p53 but requires the anti-apoptotic pathway, 
PI3K/Akt [155]. While sestrin-2 has been found to aid in inhibition of cancer cell growth, 
recently a cell protective role was discovered whereby it leads to enhanced activation of 
pro-survival Akt following 2-DG-induced oxidative and genotoxic stress [155]. The role 
of Sestrin-2 as a pro- or anti-apoptotic protein is still not fully understood however, 
strong evidence does exist showing sestrin-2 expression inhibits cell growth and 
proliferation in response to genotoxic stresses [156,157] and it is hypothesized that this 
signaling molecule may play a role in RE’s anticancer mechanism. Unfortunately little 
has been done to examine any underlying mechanisms involved in RE’s antiproliferative 
activity. In cancer-preventative models, RE has been shown to inhibit carcinogen-induced 
DNA strand breaks and oxidative stress in vitro [106,112,116] and in vivo [121–123] 
however, it is possible that it plays an opposing role as a chemotherapeutic (treatment 
option).Two studies supporting this hypothesis of RE-associated increases in oxidative 
stress showed that RE induced endoplasmic reticular stress leading to apoptosis in 
prostate cancer cells [118] and increased nitric oxide (NO) production leading to NO-
induced apoptosis in pancreatic cancer cells [110].  
Investigation of the Biological Effects of Rosemary Extract in Human Lung Cancer Cells        
 
96 
 
 Pro-apoptotic p53 plays a critical role in sensing oxidative and genotoxic stresses 
and has been shown to be activated in response to these events in cancer cells [158]. p53 
can inhibit cell growth by activating AMPK and subsequently inhibiting mTOR [158] or 
by inhibiting Akt activity through several mechanisms, one of which is enhancing PTEN 
expression [159,160] (reviewed in [161,162]). This mechanism could explain why Akt 
activity is not enhanced only in A549 cells, which express wild type p53. While H460 
cells also express normal levels of p53 (as opposed to H1299 which are p53 null) and it 
has been shown that p53 increases PTEN expression in this cell line, but not in H1299 
cells [160], the mutation to the PIK3CA gene which controls PI3K, located upstream of 
PTEN, may override the increased PTEN and still be able to phosphorylate Akt. 
Alternatively, other signaling molecules downstream of PI3K and Akt, such as sestrin-2 
and mTOR play a role in its activation [155]. Another possibility is that RE has a direct 
interaction with Akt and controls its phosphorylation. In support of this hypothesis, the 
glycolysis-inhibiting compound 2-DG was shown to directly activate Akt in NSCLC and 
other cancer cell lines [153] but was still capable of inhibiting cell growth and survival. 
Taken together, these results suggest the RE’s principal mechanism is to induce oxidative 
and genotoxic stress in NSCLC cells leading to apoptosis and inhibition of proliferation 
however, the mechanism varies greatly between cell lines depending on mutation status. 
 Our hypothesis that ERK phosphorylation would be inhibited in NSCLC cells was 
also disproven and surprisingly findings showed a significant dose-dependent increase in 
ERK phosphorylation in all cell lines (Figure 12). Interestingly, another group has 
recently shown that RE induces apoptosis in colon cancer cells through a nuclear factor 
erythroid 2-related factor 2 (Nrf2)/sestrin-2 pathway which requires phosphorylation of 
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ERK. Of note, the cells (HCT116 and SW480) used in this study contained mutant RAS 
genes which are also found in all NSCLC cells used in the current study and can lead to 
enhanced Ras-MAPK signaling [143]. This study used comparable RE concentrations 
(20-60µg/mL) and time-course (24h) to our own. RE increased nuclear localization of 
Nrf2 (active form, compared to inactive cytoplasmic form) and activation of ERK, which 
is reportedly required for Nrf2 localization to occur [143]. Nrf2 is known to interact with 
the antioxidant response element (ARE) which regulates many proteins including sestrin-
2, glutathione peroxidase (GPX1), glutathione S-transferase (GSTP1) and superoxide 
dismutase (SOD1). Interestingly, sestrin-2 was clearly upregulated in both cell lines but 
no significant effects were seen in any of the other ARE-regulated proteins. This 
evidence supports a role for sestrin-2 in RE-mediated apoptosis/inhibition of cell growth 
in NSCLC as mentioned earlier. Additionally, Nrf2 and sestrin-2 expression were both 
significantly enhanced in vivo by RE treatment (100mg/kg/day; 28days) using a mouse 
xenograft model [143]. Nrf2 has been shown to be a direct substrate of protein kinase 
RNA-like endoplasmic reticulum kinase (PERK) which is involved in the unfolded 
protein response, a cellular stress-response mechanism [163]. Increased expression of 
PERK and phosphorylated PERK was observed [143]. In support of this, members of the 
same group have previously shown RE induces endoplasmic reticular stress and enhances 
apoptosis in prostate cancer cells [118]. This study suggested that in addition to the Nrf2 
pathway activating sestrin-2, another mechanism may be involved, because silencing of 
Nrf2 (using siRNA technique) did not inhibit RE-induced sestrin-2 expression. This 
supports a potential role for the p53/Akt/mTOR/sestrin-2 axis described earlier.  
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 Expression of Akt, ERK and AMPK proteins was inhibited dose-dependently in 
all NSCLC cells (Figure 11-13). Inhibition of total protein levels are generally an 
indication that the gene is being transcriptionally regulated and mRNA levels are also 
inhibited however unfortunately PCR (to detect mRNA levels) was not performed in the 
current study. Inhibition of total Akt protein and mRNA levels by RE (50µg/mL; 48h and 
24h respectively) has previously been reported in K562 leukemia cells [117] which 
supports that RE may also act transcriptionally in NSCLC to inhibit Akt mRNA 
expression (phosphorylated Akt levels not examined). Interestingly this study also 
examined total ERK protein expression but found no inhibition by RE. This may be 
associated with the different characteristics of each cell line. Given that ERK is involved 
in regulating differentiation and K562 cells are highly undifferentiated [164] RE may not 
target this pathway in this cell line. It has been suggested that inhibition of Akt protein 
expression may be part of a process whereby cells commit to apoptosis by removal of 
anti-apoptotic proteins [161] and this may hold true for ERK and AMPK expression in 
NSCLC.   
5.3 CA and RA, polyphenols found in RE, inhibit lung cancer cell 
proliferation and survival 
 
 Rosemary extract consists of various polyphenols which have also been shown on 
their own to have anticancer properties. Present in the largest quantity are CA, RA and 
carnosol [105]. Since RE was shown to have significant anticancer effects, we wished to 
explore if these effects were attributable to an individual polyphenol. The quantity of CA 
and RA present in the extract used for this study were determined by HPLC analysis 
previously (Madina Naimi, MSc Thesis). Relative concentrations of CA and RA were 
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found to be 2.12 and 13.39% respectively. These concentrations are in the same range as 
levels of CA and RA which have been found by previous studies [108,109,143,147].  
The present study showed significant inhibition of proliferation by CA at 25µM in 
H460, 50µM in H1299 NSCLC and 100µM in A549 (Figure 14). Significant inhibition 
by RA was seen at 25µM in H460 and at 100µM in A549 and H1299 (Figure 19). 
Interestingly the levels of inhibition were comparable between the two compounds in 
each cell line. Significant inhibition of clonogenic survival by CA (Figure 15) and RA 
(Figure 20) was also seen in each cell line. The survival assay (7 days) results showed 
that NSCLC cells are much more sensitive to CA than RA. This varies from the results of 
the proliferation assay (3 days) which showed similar sensitivity of the NSCLC to both 
CA and RA. These assays differ in length (7 days and 3 days) and thus, these results 
could suggest that CA inhibits cell growth more efficiently over a longer period of time 
compared to RA. Alternatively the difference could arise from clonogenic survival being 
a more sensitive assay for detecting cell growth/survival. A study by Yesil-Celiktas et al, 
2010 found that while CA had significant inhibitory effects on cell viability at doses of 
18-150µM, RA at similar concentrations had no effect and even caused a slight increase 
in cell viability [113]. A possible reason for the lack of inhibition seen by Yesil-Celiktas 
et al, 2010 is that the concentrations used in their study are lower than what has been used 
to show inhibition in the literature. Most studies see significant inhibition using 100-
300µM RA [144,147]. Another possibility is the sensitivity of the cell lines used. The 
NSCLC cells used in the present study appear to be more sensitive, at least to RA 
compared to other cell lines seen in the literature. Both CA and RA have been shown to 
inhibit cell proliferation or enhance apoptosis at similar concentrations to those used in 
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this study in colon [109,165], pancreas [110], breast [113,166] and leukemia [113,145] 
cancer cells, among others. Importantly, both compounds have also shown anticancer 
effects in vivo by inhibiting tumor growth and formation of preneoplastic lesions, and 
increasing animal survival time [167–170].  
It was hypothesized that CA and RA would work synergistically to induce a 
greater inhibition of cell growth and results showed this to be true in A549 NSCLC cells. 
Synergism has been shown previously between CA and RA as well as carnosol, another 
RE polyphenol, in colon and pancreatic cancer cell lines [109] and suggests that perhaps 
all of the components of RE, or at least the polyphenols, work synergistically to exert 
RE’s potent anticancer effects. Our study presents strong supporting evidence of this by 
demonstrating that CA and RA alone, at the concentrations found in RE, show inhibition 
of cell proliferation and alteration of cell signaling pathways to a lesser extent than RE. 
Thus use of the complete extract may be more beneficial as a cancer preventive/treatment 
option rather than CA or RA alone. 
Both RA and CA have shown reasonable bioavailability in vivo in animal models. 
The levels of RA in mouse plasma and intestinal tract were found to be 1.1µM and 
38nmol/g respectively after chronic (8 week) ingestion of 360 mg/Kg/day RA 
(~9mg/mouse/day) showing that quantifiable levels of the parent compound are present 
after ingestion and may help slow colorectal adenoma development [171]. Surprisingly, 
another study reported an LD50 of 169.9mg/Kg/day and stated doses as low as 1-
2mg/Kg/day significantly inhibited tumor growth in mice implanted with Lewis lung 
carcinoma cells [172]. In agreement with the latter study, two groups found RA capable 
of reducing DMH-induced DNA damage and aberrant crypt foci (preneoplastic lesions) 
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in rat models of colon carcinogenesis using low doses of 4-16 mg/Kg/day [169,173]. 
Although there are still discrepancies regarding effective doses of RA in vivo, the 
literature supports its potential as a chemotherapeutic and shows it can be found in 
quantifiable levels in vivo. A study in vitro in Caco-2 cells showed CA had a 
bioavailability of 19-34% [174]. Similarly, in vivo in rats oral administration of 65mg/Kg 
CA had a bioavailability of 40.1% and resulted in a plasma concentration of 105µM 
[175]. Thus, it seems reasonable that the concentrations of RE used in most in vivo 
studies (~100mg/Kg) which would be approximately 35mg/Kg of diterpenes would be 
readily absorbed and achieve concentrations consistent with those of CA and RA used in 
cell culture in the 10-100µM range [143].  
5.4 Exploring signaling molecules involved in CA and RA’s anticancer 
mechanisms  
 
In section 5.2, we showed that RE at 25 and 50µg/mL affected the Akt, ERK and 
AMPK signaling molecules differently in each NSCLC cell line used depending on their 
mutation status. Low levels of CA and RA, equivalent to the concentrations found in 
50µg/mL RE, caused no significant alteration to Akt, ERK or AMPK signaling. 
However, at 50µM both CA and RA altered these pathways in a similar manner to RE in 
each cell line, although to a lesser extent. In A549 cells 50µM CA and RA inhibited Akt 
activation (Figure 16A, 21A) and enhanced ERK activation (Figure 17A, 22A) however, 
neither polyphenol significantly affected AMPK activity (Figure 18A, 23A). In H460 
cells 50µM CA and RA enhanced Akt (Figure 16B, 21B) and ERK (Figure 17B, 22B) 
activation as seen with RE but had no effect on AMPK (Figure 18B, 23B). Finally, in 
H1299 cells 50µM CA and RA inhibited Akt (Figure 16C, 21C) and enhanced ERK 
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(Figure 17C, 22C) and AMPK (Figure 18C, 23C) activation. As previously stated, the 
A549 and H460 cell lines lack LKB1 and this may explain the lack of activation of 
AMPK.  CA and RA similar to RE may act via LKB1 to activate AMPK. Increased 
AMPK activation was seen in H1299 cells that are LKB1 positive. The inhibition of Akt 
activity in A549 and H1299 cells seen using CA and RA alone differs from what was 
found using RE (Figure 11-13). This suggests that while CA and RA’s anticancer 
mechanism may involve inhibition of Akt activity at higher doses, the amounts found 
naturally in RE are not sufficient to induce inhibition of this pathway. This finding may 
support the use of standardized rosemary extracts which contain greater amounts of CA 
or RA and have been used previously [109,115,116,118] to show significant inhibition of 
cancer cell growth. Alternatively, other components present in RE are responsible for the 
enhanced Akt activity that was seen in H460 and H1299 cells.   
CA and RA have been shown to inhibit cell proliferation and induce apoptosis by 
various mechanisms in different cancer cell lines. Inhibition of Akt phosphorylation by 
CA has been shown in leukemia [176], hepatoma [177], colon [142] and prostate [178] 
cancer cells and by RA in colon cancer cells [172], supporting the Akt inhibition seen in 
A549 and H1299 cells by both compounds. Unfortunately no studies have been 
performed examining the role of CA or RA on AMPK in any NSCLC or other cancer cell 
lines. However, a recent study claimed RA had an anti-Warburg effect and suppressed 
glucose uptake and lactate production and inhibited expression of Hif1α which affects the 
glycolytic pathway [144] in vitro in gastric cancer cells and in vivo in a mouse gastric 
carcinoma xenograft model. AMPK is largely involved in regulating energy levels within 
the cell, and suppression of glucose uptake would lead to an increased AMP:ATP ratio 
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thus activating AMPK (in cells expressing LKB1). Therefore this study supports the 
potential role of AMPK-activation seen in the present study by CA and RA in H1299 
cells. Interestingly, CA and RA have been shown to inhibit ERK phosphorylation in 
colon cancer [142,165,172], leukemia [176] and neuroblastoma [179] cells however both 
compounds were found to induce activation of ERK in all NSCLC cell lines in our study. 
It was proposed that RE induces ERK activation through a Nrf2/ARE/Sestrin2 dependent 
pathway, and strong evidence also supports the role of Nrf2/ARE-regulated apoptosis by 
CA in rat liver clone 9 cells [180,181], neuroblastoma [179], glioblastoma [182] and 
leukemia [183] cells, albeit through slightly different mechanisms in each cell line. No 
studies have explored this mechanism using RA however, CA and RA showed similar 
effects on NSCLC cell signaling in this study and share similar chemical structures, thus 
their mechanisms are likely similar. Taken together the results suggest that CA and RA 
contribute to RE’s anticancer effects but are not solely responsible and it is likely the 
interaction of multiple components within the extract that give RE its potent anticancer 
effects. 
Total protein levels were not affected by CA or RA in any cell line and this is 
supported by previous reports that RE polyphenols do not alter protein expression 
[117,172,177,179]. Terpinolene, a non-polyphenolic component of RE, inhibited Akt 
expression in a leukemic cell line [117] and may contribute to the inhibition of total 
protein levels seen by RE in the current study. Thus, it is likely the presence of other, 
non-polyphenolic compounds in RE that lead to its inhibition of protein expression.  
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5.5 Limitations and future directions 
 
One limitation to this study is that it was performed in vitro using a cell culture 
model and has limited applicability and generalizability physiologically, towards human 
models of cancer. However, cell culture is a well-established model for exploring the 
anticancer effects of novel compounds to determine their potential use in vivo and to 
establish toxic doses. The major advantage of using cell culture is the consistency and 
reproducibility of results and that the cellular environment can be easily manipulated to 
examine different conditions. Second, RE contains many different compounds besides 
CA and RA which were not examined in this study. It would be interesting to see if other 
polyphenols such as carnosol and rosmanol had the same effects in each cell line as CA 
and RA. As well, as suggested in the discussion components of RE besides the 
polyphenols may have an effect on protein expression levels in cancer cells and it would 
have been interesting to explore some of these compounds, such as terpinolene.  
We chose to examine Akt, ERK and AMPK signaling molecules as a 
representation of how each pathway was affected in cancer however, because cancer cell 
signaling is so complex it would have been beneficial to look at more downstream 
signaling molecules such as mTOR, p70S6K, 4EBP1 or ACC. As well it would have 
benefited the strength of the study to include some measure of RE’s effects on apoptosis 
of NSCLC cells.  
Future studies should explore these downstream signaling molecules in vitro and 
examine apoptosis using cell cycle analysis or by Western blotting for apoptotic proteins 
such as p53, PARP or caspases. As well, the involvement of Nrf2 and sestrin2 in RE’s 
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mechanisms in NSCLC should be explored to confirm the hypothesis discussed in section 
5.2 (RE signaling mechanisms). The finding that RE inhibited protein expression of Akt, 
ERK and AMPK in all cell lines was proposed to be a result of RE altering mRNA 
expression and PCR analysis should be performed to explore this hypothesis. Since the 
effects of RE on the signaling molecules in NSCLC cells were complex and varied 
between each cell line it would be interested to use inhibitors or a silencing technique to 
knockdown expression of Akt, ERK and AMPK and examine how this altered the 
anticancer effects seen by RE. Combination therapies are useful in treating cancer 
because they can target different signaling pathways at once and future studies should 
investigate RE’s effect in combination with current chemotherapeutic agents such as 
cisplatin, or other natural compounds that have shown anticancer activity such as 
resveratrol and metformin.  
Once more is known about RE’s anticancer mechanism in vitro, studies should be 
performed using in vivo xenograft lung cancer models in mice or rats. These studies 
could confirm findings from in vitro studies and further examine toxic doses and 
bioavailability of RE to support its use in human clinical trials.  
 
5.6 Summary/Conclusions  
 
 Lung cancer is the leading cause of cancer related deaths and NSCLC accounts 
for over 80% of all lung cancer cases and represents the most aggressive form of the 
disease. Thus, various NSCLC cell lines were used in this study to represent different 
histologies and mutations that would be found in patients. Rosemary extract has a high 
polyphenolic content and is associated with the beneficial effects of a Mediterranean diet 
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thus, it has recently gained attention for its health effects, including anticancer activity. 
Two of RE’s polyphenols CA and RA have also been shown to exhibit anticancer 
properties. This study aimed to examine the anticancer effects of RE in NSCLC cells and 
potential underlying signaling mechanisms. We also wished to determine if the 
polyphenols CA and RA exhibited anticancer effects in NSCLC cells and if they were 
responsible, at least in part, for RE’s actions. 
The present study found RE inhibited NSCLC cell proliferation and survival 
significantly at low concentrations (2.5-10µg/mL). The signaling proteins Akt, ERK and 
AMPK were found to be involved however, RE’s growth inhibitory mechanisms varied 
by cell line. These findings supported a role for RE as a potential chemopreventive or 
chemotherapeutic agent, if used in combination with an Akt inhibitor. Findings also 
support a novel role of RE to activate ERK as an apoptotic mechanism, through an 
Nrf2/ARE/Sestrin2 pathway, at least in NSCLC cells. The polyphenols CA and RA did 
not have significant anticancer activity at low concentrations comparable to those found 
in effective RE doses however, at higher concentrations both compounds significantly 
inhibited cell survival and proliferation. Both CA and RA also significantly altered 
activity of Akt, ERK and AMPK signaling proteins at 50µM in NSCLC. Therefore, while 
CA and RA may not be responsible in full, they likely play a role in RE’s anticancer 
activity. The current study supports the potential use of RE as an anticancer agent in 
NSCLC and provides novel findings on RE’s growth inhibitory mechanisms which 
should be explored further using in vivo and tumor xenograft animal models.  
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Appendix 
 
Supplemental Figures 
 
 
 
 
Figure s1: Treatment of NSCLC cells with 0.1% DMSO has no effect on cell 
proliferation. A) A549 B) H460 and C) H1299 cells were seeded in triplicate and 
incubated with 0.1% DMSO for 72h followed by fixing and staining with 0.5% crystal 
violet. Stain was solubilized and absorbance was read at 570nm. Results are expressed as 
the mean ± SEM compared to untreated control of 3 individual experiments. 
 
 
  
